col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


584 Ergebisse       Seite 1

 [1] 
Frontiers Media SA: Frontiers in Pharmacology
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Mai―09 Vitamin D level in COVID-19 patients has positive correlations with autophagy and negative correlations with disease severity Hongna Dong, Yuqiu Hao, Peng Gao
2 [GO] 2024―Apr―09 Statins use amidst the pandemic: prescribing, dispensing, adherence, persistence, and correlation with COVID-19 statistics in nationwide real-world data from Poland Przemysław Kardas, Angelika Kwiatek, Piotr Włodarczyk, Filip Urbański, Beata Ciabiada-Bryła
3 [GO] 2024―Mrz―27 Case report: Paralytic ileus resulted from nirmatrelvir/ritonavir-tacrolimus drug-drug interaction in a systemic lupus erythematosus patient with COVID-19 Wei Zhang, Xingguo Zhang, Jinming Han, Wen Zhang, Jiarui Xu, Xin Zhang, et al. (+6)
4 [GO] 2024―Feb―28 Prenatal maternal inactivated COVID-19 vaccination: the maternal and neonatal outcomes, a retrospective cohort study Yaoyao Cai, Shenghao Wu, Sisi Zhang, Xinxin Xu, Fengfeng Xie, Lijun Gao, Weiting Xia
5 [GO] 2024―Feb―23 Identifying in-market application of Pelargonium root extract EPs 7630 for the treatment of COVID-19: analysis of pharmacovigilance data Fathi Abdul Malek, Petra Funk
6 [GO] 2024―Feb―20 The characteristics and operations of “online pharmacies” investigated in relation to medicines popularised during the coronavirus pandemic: a cross-sectional study Oria Jason Oriakhi, Hamzeh Almomani, Nilesh Patel, Parastou Donyai
7 [GO] 2024―Feb―15 The effectiveness of oral anti-SARS-CoV-2 agents in non-hospitalized COVID-19 patients with nonalcoholic fatty liver disease: a retrospective study Chun-Chi Yang, Ya-Wen Tsai, Su-Hung Wang, Jheng-Yan Wu, Ting-Hui Liu, Wan-Hsuan Hsu, et al. (+4)
8 [GO] 2024―Feb―07 Pharmacological targeting of the hyper-inflammatory response to SARS-CoV-2-infected K18-hACE2 mice using a cluster of differentiation 36 receptor modulator Jade Gauvin, David N. Huynh, Isabelle Dubuc, Catherine Lê, Rafaela Tugores, Nicolas Flamand, et al. (+4)
9 [GO] 2024―Feb―06 Individual ingredients of NP-101 (Thymoquinone formula) inhibit SARS-CoV-2 pseudovirus infection Abdelrahim Maen, Betul Gok Yavuz, Yehia I. Mohamed, Abdullah Esmail, Jianming Lu, Amr Mohamed, et al. (+9)
10 [GO] 2024―Jan―22 Unraveling the impact of nitric oxide, almitrine, and their combination in COVID-19 (at the edge of sepsis) patients: a systematic review Ying Wang, Qian Yu, Yuan Tian, Shiying Ren, Liping Liu, Chaojie Wei, et al. (+4)
11 [GO] 2024―Jan―16 Efficacy and safety of aniseed powder for treating gastrointestinal symptoms of COVID-19: a randomized, placebo-controlled trial Maryam Mosaffa-Jahromi, Hossein Molavi Vardanjani, Andrea Fuzimoto, Jennifer Hunter, Kamran Bagheri Lankarani, Mehdi Pasalar
12 [GO] 2024―Jan―10 Pharmacokinetics of recombinant human annexin A5 (SY-005) in patients with severe COVID-19 Brent J. Tschirhart, Xiangru Lu, Aristide Laurel Mokale Kognou, Claudio M. Martin, Marat Slessarev, Douglas D. Fraser, et al. (+3)
13 [GO] 2024―Jan―08 Assessing the efficacy and safety of Yinqiao powder-maxing Ganshi decoction in the treatment of the major symptoms of mild and moderate COVID-19 by telemedicine-study protocol for a randomized, double-blind, placebo-controlled trial Chi Him Sum, Tong Wendy Li, Hongwei Zhang, Hing Yu Hung, Ben Yuk Fai Fong, Wai Ling Lin, et al. (+6)
14 [GO] 2024―Jan―03 Klotho-derived peptide KP1 ameliorates SARS-CoV-2-associated acute kidney injury Jie Xu, Enqing Lin, Xue Hong, Li Li, Jun Gu, Jinghong Zhao, Youhua Liu
15 [GO] 2023―Dez―22 Identification of oral therapeutics using an AI platform against the virus responsible for COVID-19, SARS-CoV-2 Adam Bess, Frej Berglind, Supratik Mukhopadhyay, Michal Brylinski, Chris Alvin, Fanan Fattah, Kishor M. Wasan
16 [GO] 2023―Dez―08 Efficacies of S-nitrosoglutathione (GSNO) and GSNO reductase inhibitor in SARS-CoV-2 spike protein induced acute lung disease in mice Judong Kim, Fei Qiao, Avtar K. Singh, Jeseong Won, Inderjit Singh
17 [GO] 2023―Dez―06 Evaluation of the efficacy and safety of nirmatrelvir/ritonavir co-administration inpatients with rheumatic disease infected with SARS-CoV-2: a real-world study Xue Zhong, Chao Wang, Lin Huang, Yue Zhao, Tianyi Li, Jing He, Xiaohong Zhang
18 [GO] 2023―Dez―05 Association of antihypertensive drugs with COVID-19 outcomes: a drug-target Mendelian randomization study Kun Zhang, Hengxing Gao, Mingwei Chen
19 [GO] 2023―Dez―01 Safety and efficacy of lentinan nasal drops in patients infected with the variant of COVID-19: a randomized, placebo-controlled trial Wenhan Fan, Benming You, Xinyu Wang, Xu Zheng, Aijing Xu, Yangang Liu, et al. (+7)
20 [GO] 2023―Nov―23 Efficacy and safety of tocilizumab and baricitinib among patients hospitalized for COVID-19: a systematic review and meta-analysis Jin Zhang, Xiongxiong Fan, Xiaoyu Zhang, Fengli Jiang, Yiping Wu, Beibei Yang, et al. (+2)
21 [GO] 2023―Nov―16 Efficacy and safety of molnupiravir in patients with Omicron variant vaccine breakthrough COVID-19 infection: a randomized, controlled trial Yayun Liu, Shiyong Fan, Aijing Xu, Lingling Ge, Xinyu Wang, Xu Dong, et al. (+4)
22 [GO] 2023―Nov―16 Diagnostics and treatments of COVID-19: two-year update to a living systematic review of economic evaluations Jamie Elvidge, Gareth Hopkin, Nithin Narayanan, David Nicholls, Dalia Dawoud
23 [GO] 2023―Nov―14 An updated meta-analysis of Chinese herbal medicine for the prevention of COVID-19 based on Western-Eastern medicine Siying Hu, Dan Luo, Qikui Zhu, Jie Pan, Bonan Chen, Michael Furian, et al. (+8)
24 [GO] 2023―Nov―07 Computer-aided drug design for virtual-screening and active-predicting of main protease (Mpro) inhibitors against SARS-CoV-2 Renhui Dai, Hongwei Gao, Ruiling Su
25 [GO] 2023―Nov―03 Statutory health insurance-covered pre-exposure prophylaxis in Germany: changing trends in nationwide tenofovir disoproxil/emtricitabine prescriptions during the COVID-19 pandemic Henrieke Prins, Achim Dörre, Daniel Schmidt
26 [GO] 2023―Nov―01 Associations between COVID-19 outcomes and asthmatic patients with inhaled corticosteroid Su-Boon Yong, Shuo-Yan Gau, Chia-Jung Li, Chih-Wei Tseng, Shiow-Ing Wang, James Cheng-Chung Wei
27 [GO] 2023―Okt―30 Do disease-modifying antirheumatic drugs and non-steroidal anti-inflammatory drugs increase the burden on ankylosing spondylitis patients with mild-moderate COVID-19? evidence from a retrospective cohort study Yan Li, Zhengyuan Hu, Yufei Guo, Zheng Zhao, Kunpeng Li, Xiuru Wang, et al. (+6)
28 [GO] 2023―Okt―19 The effects of combination-therapy of tocilizumab and baricitinib on the management of severe COVID-19 cases: a randomized open-label clinical trial Farzaneh Dastan, Hamidreza Jamaati, Saghar Barati, Shahrzad Varmazyar, Sahar Yousefian, Elmira Niknami, Payam Tabarsi
29 [GO] 2023―Okt―13 Head-to-head comparison of azvudine and nirmatrelvir/ritonavir for the hospitalized patients with COVID-19: a real-world retrospective cohort study with propensity score matching An-Hua Wei, Lu Zeng, Lu Wang, Lin Gui, Wen-Ting Zhang, Xue-Peng Gong, et al. (+2)
30 [GO] 2023―Okt―10 A retrospective real-world study of early short-course remdesivir in non-hospitalized COVID-19 patients at high risk for progression: low rate of hospitalization or death, regardless of immunocompetence status José Manuel Ramos-Rincón, Héctor Pinargote-Celorio, Jara Llenas-García, Oscar Moreno-Pérez, Inmaculada González-Cuello, Pilar Gonzalez-de-la-Aleja, et al. (+6)
31 [GO] 2023―Okt―09 Impact of domiciliary administration of NSAIDs on COVID-19 hospital outcomes: an unCoVer analysis Elena Salvador, Cristina Mazzi, Nicoletta De Santis, Giulia Bertoli, Antonija Jonjić, Miran Coklo, et al. (+3)
32 [GO] 2023―Sep―29 Corrigendum: Commentary: An evaluation of traditional Persian medicine for the management of SARS-CoV-2 Haniye Mirhosseini, Jale Aliasl, Fatemeh Eghbalian
33 [GO] 2023―Sep―19 Editorial: Re-emergence of neglected tropical diseases amid the COVID-19 pandemic: epidemiology, transmission, mitigation strategies, and recent advances in chemotherapy and vaccines Ranjan K. Mohapatra, Venkataramana Kandi, Veronique Seidel, Ali A. Rabaan
34 [GO] 2023―Aug―28 Corrigendum: The traditional Chinese medicine formula Jing Guan Fang for preventing SARS-CoV-2 infection: from clinical observation to basic research Yueh-Hsin Ping, Hsin Yeh, Li-Wei Chu, Zhi-Hu Lin, Yin-Chieh Hsu, Lie-Chwen Lin, et al. (+3)
35 [GO] 2023―Aug―25 Efficacy and safety evaluation of Azvudine in the prospective treatment of COVID-19 based on four phase III clinical trials Ke-Wei Zhu
36 [GO] 2023―Aug―16 Assessment of the proarrhythmic effects of repurposed antimalarials for COVID-19 treatment using a comprehensive in vitro proarrhythmia assay (CiPA) Seung-Hyun Yoon, Hyun-Lee Lee, Da Un Jeong, Ki Moo Lim, Seong-Jun Park, Ki-Suk Kim
37 [GO] 2023―Aug―04 A review of SARS-CoV-2 drug repurposing: databases and machine learning models Marim Elkashlan, Rahaf M. Ahmad, Malak Hajar, Fatma Al Jasmi, Juan Manuel Corchado, Nurul Athirah Nasarudin, Mohd Saberi Mohamad
38 [GO] 2023―Aug―03 COVID-19 vaccination-related autoimmune hepatitis-a perspective Consolato M. Sergi
39 [GO] 2023―Aug―03 Molecular mechanisms of COVID-19-induced pulmonary fibrosis and epithelial-mesenchymal transition Peng Pi, Zhipeng Zeng, Liqing Zeng, Bing Han, Xizhe Bai, Shousheng Xu
40 [GO] 2023―Jul―31 The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19 Binbin Xia, Li Zheng, Yali Li, Wenfang Sun, Yang Liu, Liushui Li, et al. (+4)
41 [GO] 2023―Jul―26 Corrigendum: Host factor interaction networks identified by integrative bioinformatics analysis reveals therapeutic implications in COPD patients with COVID-19 Wenjiang Zheng, Ting Wang, Peng Wu, Qian Yan, Chengxin Liu, Hui Wu, et al. (+4)
42 [GO] 2023―Jul―26 In vitro and in vivo effects of Pelargonium sidoides DC. root extract EPs® 7630 and selected constituents against SARS-CoV-2 B.1, Delta AY.4/AY.117 and Omicron BA.2 Jackson Emanuel, Jan Papies, Celine Galander, Julia M. Adler, Nicolas Heinemann, Kathrin Eschke, et al. (+8)
43 [GO] 2023―Jul―21 A retrospective study of Reyanning mixture in elderly patients infected with SARS-CoV-2 Omicron variant Changya Liu, Xinxin Wu, Hongqiang Yang, Xiangru Xu, Caiyu Chen, Linguangjin Wu, et al. (+7)
44 [GO] 2023―Jul―15 Editorial: Opioids in the time of the COVID-19 pandemic: from cellular mechanisms to public health policy Scott John, David R. Walwyn, Kathryn DeFea, Tim G. Hales, Wendy Walwyn
45 [GO] 2023―Jul―14 Editorial: Coronavirus disease (COVID-19): mechanistic basic, translational, and clinical research aimed at identification of effective preventive and therapeutic strategies Paolo Montuschi, Fatih M. Uckun, Alastair George Stewart, Paola Patrignani
46 [GO] 2023―Jul―12 Potential pharmacokinetic interactions with concurrent use of herbal medicines and a ritonavir-boosted COVID-19 protease inhibitor in low and middle-income countries Dallas J. Smith, Huichang Bi, Josias Hamman, Xiaochao Ma, Constance Mitchell, Kumbukani Nyirenda, et al. (+7)
47 [GO] 2023―Jun―30 Evaluation of safety and effectiveness of remdesivir in treating COVID-19 patients after emergency use authorization study Erlina Burhan, Elisna Syahruddin, Fathiyah Isbaniah, Ginanjar Arum Desianti, Fanny Fachrucha, Cut Yulia Indah Sari, et al. (+9)
48 [GO] 2023―Jun―24 COVID-19 vaccination effectiveness and safety in vulnerable populations: a meta-analysis of 33 observational studies Hui-Jun Li, Qi-Chao Yang, Yang-Yang Yao, Cheng-Yang Huang, Fu-Qiang Yin, Chen-Yang Xian-Yu, et al. (+2)
49 [GO] 2023―Jun―24 Association between genetic polymorphism, severity, and treatment response among COVID-19 infected Egyptian patients Abdelrahman Alaa, Neven Sarhan, Mohamed Gamal Lotfy El-Ansary, Naglaa Samir Bazan, Khaled Farouk, Raed Shahat Ismail, et al. (+2)
50 [GO] 2023―Jun―22 Garbage in, garbage out: how reliable training data improved a virtual screening approach against SARS-CoV-2 MPro Santiago M. Ruatta, Denis N. Prada Gori, Martín Fló Díaz, Franca Lorenzelli, Karen Perelmuter, Lucas N. Alberca, et al. (+53)
51 [GO] 2023―Jun―21 NRICM101 ameliorates SARS-CoV-2-S1-induced pulmonary injury in K18-hACE2 mice model Wen-Chi Wei, Keng-Chang Tsai, Chia-Ching Liaw, Chun-Tang Chiou, Yu-Hwei Tseng, Geng-You Liao, et al. (+6)
52 [GO] 2023―Jun―16 Mendelian randomization analysis identified tumor necrosis factor as being associated with severe COVID-19 Hongfei Song, Na Lei, Ling Zeng, Xiuyan Li, Cen Jiang, Quansheng Feng, et al. (+3)
53 [GO] 2023―Jun―15 Pharmacological approaches to pulmonary fibrosis following COVID-19 Stefan Lassan, Tomas Tesar, Jana Tisonova, Monika Lassanova
54 [GO] 2023―Jun―15 The impact of immunotherapies on COVID-19 case fatality rates during the US vaccination campaign: a multidisciplinary open data analysis using FDA Adverse Event Reporting System and Our World in Data Anke Salmen, Stefanie Marti, Andreas G. F. Hoepner, Andrew Chan, Robert Hoepner
55 [GO] 2023―Jun―14 A report on SARS-CoV-2 first wave in Ecuador: drug consumption dynamics Andrea Orellana-Manzano, Fernanda B. Cordeiro, Andrea Garcia-Angulo, Elizabeth Centeno, María José Vizcaíno-Tumbaco, Sebastián Poveda, et al. (+5)
56 [GO] 2023―Jun―06 Editorial: Pharmacological and biochemical perspectives of kinase inhibitors in cancer and COVID-19 therapeutics Balakumar Chandrasekaran, Muthupandian Saravanan
57 [GO] 2023―Jun―05 A retrospective analysis of factors associated with the length of hospital stay in COVID-19 patients treated with Nirmatrelvir / Ritonavir Jiantao Zheng, Wencong Hong, Chanjuan Zhou, Donghuang Hong, Hong Yan, Yanghui Shen
58 [GO] 2023―Mai―31 Prophylactic rivaroxaban in the early post-discharge period reduces the rates of hospitalization for atrial fibrillation and incidence of sudden cardiac death during long-term follow-up in hospitalized COVID-19 survivors Lukas Fiedler, Lukas J. Motloch, Anna-Maria Dieplinger, Peter Jirak, Paruir Davtyan, Diana Gareeva, et al. (+14)
59 [GO] 2023―Mai―31 Corrigendum: COVIEdb: A Database for Potential Immune Epitopes of Coronaviruses Jingcheng Wu, Wenfan Chen, Jingjing Zhou, Wenyi Zhao, Yisheng Sun, Hanping Zhu, et al. (+4)
60 [GO] 2023―Mai―25 Opioid use in the era of COVID-19: a multifaceted study of the opioid epidemic in Canada Molly Hutchinson, Éric Lavigne, Zachary Patterson
61 [GO] 2023―Mai―19 Elevated INR in a COVID-19 patient after concomitant administration of azvudine and anticoagulants Xi Zhang, Fengwei Jiao, Guangrun Li, Xiaojia Yu, Yuqing Pei, Ying Zhang, et al. (+2)
62 [GO] 2023―Mai―18 In silico evidence implicating novel mechanisms of Prunella vulgaris L. as a potential botanical drug against COVID-19-associated acute kidney injury Xue-Ling Yang, Chun-Xuan Wang, Jia-Xing Wang, Shi-Min Wu, Qing Yong, Ke Li, Ju-Rong Yang
63 [GO] 2023―Mai―15 Impact of COVID-19 epidemic on antihypertensive drug treatment disruptions: results from a nationwide interrupted time-series analysis Clément Mathieu, Julien Bezin, Antoine Pariente
64 [GO] 2023―Mai―15 Olmesartan alleviates SARS-CoV-2 envelope protein induced renal fibrosis by regulating HMGB1 release and autophagic degradation of TGF-β1 Shilin Zhou, Zanzhe Yu, Zihui Chen, Fengling Ning, Xuetao Hu, Tiangang Wu, et al. (+4)
65 [GO] 2023―Mai―12 Nirmatrelvir/Ritonavir for hemodialysis patients with COVID-19 Jiayue Lu, Hong Cai, Yujun Hao, Zhang Lin, Shang Liu, Yaping Zhan, et al. (+12)
66 [GO] 2023―Mai―05 QSAR and molecular docking studies on designing potent inhibitors of SARS-CoVs main protease Fucheng Song, Haoyang Sun, Fangxiao Ma, Wei Wang, Mingyuan Luan, Honglin Zhai, et al. (+2)
67 [GO] 2023―Mai―04 One stone two birds: anti-inflammatory bronchodilators as a potential pharmacological strategy for COVID-19 Yuanyuan Yu, Bangjiang Fang, Xiao-Dong Yang, Yuejuan Zheng
68 [GO] 2023―Apr―27 Editorial: Emerging mechanistic insights of selective and Nonselective Autophagy in liver and gut diseases and their treatment strategies in the era of COVID-19 Md. Abdul Alim Al-Bari, Manoj B. Menon, Nabil Eid
69 [GO] 2023―Apr―27 Low molecular weight heparin in COVID-19: benefits and concerns Adham Makarem, Rana Zareef, Joseph Abourjeili, Joseph E Nassar, Fadi Bitar, Mariam Arabi
70 [GO] 2023―Apr―27 SARS-CoV-2 infection dysregulates the expression of clinically relevant drug metabolizing enzymes in Vero E6 cells and membrane transporters in human lung tissues Chukwunonso K. Nwabufo, Md. Tozammel Hoque, Lily Yip, Maliha Khara, Samira Mubareka, Michael S. Pollanen, Reina Bendayan
71 [GO] 2023―Apr―25 Trends and characteristics of COVID-19 and cardiovascular disease related studies Ao Cheng, Honghao Ren, Zeyao Ma, Naqash Alam, Linying Jia, Enqi Liu
72 [GO] 2023―Apr―17 Olive Leaves as a Potential Phytotherapy in the Treatment of COVID-19 Disease; A Mini-Review Shimaa M. Abdelgawad, Mahmoud A. El Hassab, Mohammed A. S. Abourehab, Eslam B. Elkaeed, Wagdy M. Eldehna
73 [GO] 2023―Apr―14 Real-world evidence of autoimmune hepatitis following COVID-19 vaccination: A population-based pharmacovigilance analysis Congqin Chen, Danfei Xie, Jie Xiao
74 [GO] 2023―Mrz―24 Characterising the treatment of thromboembolic events after COVID-19 vaccination in 4 European countries and the US: An international network cohort study Aniek F. Markus, Victoria Y. Strauss, Edward Burn, Xintong Li, Antonella Delmestri, Christian Reich, et al. (+8)
75 [GO] 2023―Mrz―23 Prevalence of COVID-19 outcomes in patients referred to opioid agonist treatment centers Samira Khani, Javad Tafaroji, Mehdi Yaghoubi, Mohammad Javad Emami Kazemabad, Seyed Amir Hejazi
76 [GO] 2023―Mrz―22 Nirmatrelvir/ritonavir for patients with SARS-CoV-2 infection and impaired kidney function during the Omicron surge Jiayi Yan, Hong Cai, Jieying Wang, Mingli Zhu, Ping Li, Peiying Li, et al. (+4)
77 [GO] 2023―Mrz―17 Sales trends of psychotropic drugs in the COVID-19 pandemic: A national database study in Brazil Fernando de Sá Del Fiol, Cristiane de Cássia Bergamaschi, Luciane Cruz Lopes, Marcus Tolentino Silva, Silvio Barberato-Filho
78 [GO] 2023―Mrz―15 Antibiotic consumption and antimicrobial resistance in the SARS-CoV-2 pandemic: A single-center experience Dragana Sokolović, Dragana Drakul, Vesna Vujić-Aleksić, Bojan Joksimović, Siniša Marić, Lana Nežić
79 [GO] 2023―Mrz―13 Ginsenosides, potential TMPRSS2 inhibitors, a trade-off between the therapeutic combination for anti-PD-1 immunotherapy and the treatment of COVID-19 infection of LUAD patients Mei Meng, Rui Gao, Zixue Liu, Fengxiang Liu, Shiyu Du, Yizhi Song, Jian He
80 [GO] 2023―Mrz―09 Editorial: Medication safety in COVID-19 management, Volume II Saibal Das
81 [GO] 2023―Mrz―09 An update on SARS-CoV-2 immunization and future directions Rashmi Rana, Ravi Kant, Tanya Kumra, Sneha Gupta, Devinder Singh Rana, Nirmal Kumar Ganguly
82 [GO] 2023―Mrz―01 Innovative, rapid, high-throughput method for drug repurposing in a pandemic-A case study of SARS-CoV-2 and COVID-19 Shaibu Oricha Bello, Abdulmajeed Yunusa, Adamu Ahmed Adamu, Mustapha Umar Imam, Muhammad Bashir Bello, Abdulmalik Shuaibu, et al. (+7)
83 [GO] 2023―Feb―27 Jin-Zhen oral liquid for pediatric coronavirus disease (COVID-19): A randomly controlled, open-label, and non-inferiority trial at multiple clinical centers Qian Dong, Hongmei Qiao, Huiyi Jiang, Lixiao Liu, Yanling Ge, Fang-Jiao Zong, et al. (+12)
84 [GO] 2023―Feb―17 Evaluation of noscapine-licorice combination effects on cough relieving in COVID-19 outpatients: A randomized controlled trial Saghar Barati, Faezeh Feizabadi, Hakimeh Khalaj, Hakimeh Sheikhzadeh, Hamid R. Jamaati, Hirad Farajidavar, Farzaneh Dastan
85 [GO] 2023―Feb―16 Traditional Tibetan medicine to fight against COVID-19: Basic theory and therapeutic drugs Kun Zhang, Lijie Wang, Jiayan Peng, Kangzhuo Sangji, Yuting Luo, Yujiao Zeng, et al. (+2)
86 [GO] 2023―Feb―15 In vitro metabolic characterization of the SARS-CoV-2 papain-like protease inhibitors GRL0617 and HY-17542 Hyunki Cho, Young Jun Kim, Jung-Woo Chae, Markus R. Meyer, Sang Kyum Kim, Chang Seon Ryu
87 [GO] 2023―Feb―09 How to use COVID-19 antiviral drugs in patients with chronic kidney disease Ajinath Kale, Vishwadeep Shelke, Neha Dagar, Hans-Joachim Anders, Anil Bhanudas Gaikwad
88 [GO] 2023―Feb―07 Variant-specific deleterious mutations in the SARS-CoV-2 genome reveal immune responses and potentials for prophylactic vaccine development Md. Aminul Islam, Shatila Shahi, Abdullah Al Marzan, Mohammad Ruhul Amin, Mohammad Nayeem Hasan, M. Nazmul Hoque, et al. (+7)
89 [GO] 2023―Feb―02 Commentary: An evaluation of traditional Persian medicine for the management of SARS-CoV-2 Haniye Mirhosseini, Jale Aliasl
90 [GO] 2023―Feb―01 Incidence and potential risk factors for remdesivir-associated bradycardia in hospitalized patients with COVID-19: A retrospective cohort study Yazed Saleh Alsowaida, Fadi Shehadeh, Markos Kalligeros, Eleftherios Mylonakis
91 [GO] 2023―Feb―01 Editorial: Cell cycle control as a new therapeutic approach for SARS-CoV-2 infection Roberta Rizzo, Francesca Caccuri, Giuseppe Valacchi, Giorgio Zauli
92 [GO] 2023―Jan―20 Rational use of drugs for the elderly during the COVID-19 pandemic in China: Challenges and opportunities Qingqing Yin, Dandan Feng, Yong Zhao, Xiaojuan Zhu, Yan Dong, Jianchun Wang
93 [GO] 2023―Jan―19 Use of traditional Chinese medicine for the treatment and prevention of COVID-19 and rehabilitation of COVID-19 patients: An evidence mapping study Yanfei Li, Yu Qin, Nan Chen, Long Ge, Qi Wang, Taslim Aboudou, et al. (+14)
94 [GO] 2023―Jan―19 Huashi baidu granule in the treatment of pediatric patients with mild coronavirus disease 2019: A single-center, open-label, parallel-group randomized controlled clinical trial Jiande Chen, Qiuyu Tang, Baoqin Zhang, Shuhua Yuan, Jia Chen, Shiyu Shen, et al. (+5)
95 [GO] 2023―Jan―17 Remdesivir associated sinus bradycardia in patients with COVID-19: A prospective longitudinal study Maryam Hajimoradi, Babak Sharif Kashani, Farzaneh Dastan, Sina Aghdasi, Atefeh Abedini, Farah Naghashzadeh, et al. (+11)
96 [GO] 2023―Jan―16 Analysis of spontaneous reports of suspected adverse reactions after vaccination against COVID-19 in Slovakia Monika Lassanova, Stefan Lassan, Silvia Liskova, Tomas Tesar, Monika Cicova
97 [GO] 2023―Jan―13 Quercetin as a possible complementary agent for early-stage COVID-19: Concluding results of a randomized clinical trial Francesco Di Pierro, Amjad Khan, Somia Iqtadar, Sami Ullah Mumtaz, Muhammad Nabeel Akbar Chaudhry, Alexander Bertuccioli, et al. (+7)
98 [GO] 2023―Jan―10 The pathological mechanism of the COVID-19 convalescence and its treatment with traditional Chinese medicine Linlin Jiang, Xuedong An, Yingying Duan, Fengmei Lian, De Jin, Yuehong Zhang, et al. (+4)
99 [GO] 2023―Jan―05 Erratum: A Retrospective Study on the Use of Chinese Patent Medicine in 24 Medical Institutions for COVID-19 in China Frontiers Production Office
100 [GO] 2022―Dez―23 Dispensing of psychotropic drugs in the Brazilian capital city before and during the COVID-19 pandemic (2018-2020) Pamela Alejandra Escalante Saavedra, Dayani Galato, Calliandra Maria de Souza Silva, Izabel Cristina Rodrigues da Silva, Emília Vitoria da Silva
101 [GO] 2022―Dez―23 Attitudes and behaviors regarding online pharmacies in the aftermath of COVID-19 pandemic: At the tipping point towards the new normal András Fittler, Tünde Ambrus, Anna Serefko, Lenka Smejkalová, Anna Kijewska, Aleksandra Szopa, Mátyás Káplár
102 [GO] 2022―Dez―20 Combination of the parent analogue of remdesivir (GS-441524) and molnupiravir results in a markedly potent antiviral effect in SARS-CoV-2 infected Syrian hamsters Rana Abdelnabi, Piet Maes, Steven de Jonghe, Birgit Weynand, Johan Neyts
103 [GO] 2022―Dez―13 Cell cycle block by p53 activation reduces SARS-CoV-2 release in infected alveolar basal epithelial A549-hACE2 cells Giada Lodi, Valentina Gentili, Fabio Casciano, Arianna Romani, Giorgio Zauli, Paola Secchiero, et al. (+6)
104 [GO] 2022―Dez―12 Emerging toolset of three-dimensional pulmonary cell culture models for simulating lung pathophysiology towards mechanistic elucidation and therapeutic treatment of SARS-COV-2 infection Kai Ni, Bo Che, Chongxin Yang, Youyuan Qin, Rong Gu, Chunhong Wang, et al. (+2)
105 [GO] 2022―Dez―12 A randomized, double-blind, placebo-controlled phase I trial of inhalation treatment of recombinant TFF2-IFN protein: A multifunctional candidate for the treatment of COVID-19 Yan Liu, Guanxing Zhai, Weihui Fu, Xiaoyan Zhang, Jianqing Xu
106 [GO] 2022―Dez―07 Beta-blockers in post-acute myocardial infarction patients: Drug prescription patterns from 2018 to Italy’s first wave of the COVID-19 pandemic Elena Olmastroni, Federica Galimberti, Alberico L. Catapano, Elena Tragni, Manuela Casula
107 [GO] 2022―Dez―01 Inhibition of coronavirus HCoV-OC43 by targeting the eIF4F complex Yongmei Feng, Stefan Grotegut, Predrag Jovanovic, Valentina Gandin, Steven H. Olson, Rabi Murad, et al. (+9)
108 [GO] 2022―Dez―01 Efficacy and safety profile of corticosteroids and non-steroidal anti-inflammatory drugs in COVID-19 management: A narrative review Seth Kwabena Amponsah, Benjamin Tagoe, Ismaila Adams, Kwasi Agyei Bugyei
109 [GO] 2022―Nov―30 Selective serotonin reuptake inhibitors: New hope in the fight against COVID-19 Mahsa Asadi Anar, Elaheh Foroughi, Elika Sohrabi, Samira Peiravi, Yasaman Tavakoli, Mozhgan Kameli Khouzani, et al. (+11)
110 [GO] 2022―Nov―30 Impact of fluvoxamine on outpatient treatment of COVID-19 in Honduras in a prospective observational real-world study Estela Pineda, Jarmanjeet Singh, Miguel Vargas Pineda, Jose Garay Umanzor, Fernando Baires, Luis G. Benitez, et al. (+18)
111 [GO] 2022―Nov―30 Hypertension related toxicity of chloroquine explains its failure against COVID-19: Based on rat model Junqi Wang, Xian Jing, Lizhong Hua, Yuling Zheng, Shiheng Hu, Jing Xiao, et al. (+6)
112 [GO] 2022―Nov―28 Drug-induced liver injury in COVID-19 treatment: Incidence, mechanisms and clinical management Xichuan Li, Wanting Wang, Suying Yan, Weipeng Zhao, Hui Xiong, Cuiping Bao, et al. (+4)
113 [GO] 2022―Nov―24 Challenges in evaluating treatments for COVID-19: The case of in-hospital anticoagulant use and the risk of adverse outcomes Ya-Hui Yu, In-Sun Oh, Han Eol Jeong, Robert W. Platt, Antonios Douros, Ju-Young Shin, Kristian B. Filion
114 [GO] 2022―Nov―24 Drug-related problems in patients admitted for SARS-CoV-2 infection during the COVID-19 pandemic J. Barceló-Vidal, D. Echeverría-Esnal, N. Carballo, M. De Antonio-Cuscó, X. Fernández-Sala, M. E. Navarrete-Rouco, et al. (+8)
115 [GO] 2022―Nov―24 Adverse drug events in the prevention and treatment of COVID-19: A data mining study on the FDA adverse event reporting system Qiang Guo, Shaojun Duan, Yaxi Liu, Yinxia Yuan
116 [GO] 2022―Nov―24 Myocarditis and pericarditis associated with SARS-CoV-2 vaccines: A population-based descriptive cohort and a nested self-controlled risk interval study using electronic health care data from four European countries Sophie H. Bots, Judit Riera-Arnau, Svetlana V. Belitser, Davide Messina, Maria Aragón, Ema Alsina, et al. (+18)
117 [GO] 2022―Nov―23 The role of IL-6 in coronavirus, especially in COVID-19 Xinyi Wang, Guozheng Tang, Yuchen Liu, Lizhi Zhang, Bangjie Chen, Yanxun Han, et al. (+8)
118 [GO] 2022―Nov―23 Discovery of the key active compounds in Citri Reticulatae Pericarpium (Citrus reticulata “Chachi”) and their therapeutic potential for the treatment of COVID-19 based on comparative metabolomics and network pharmacology Fu Wang, Lin Chen, Hongping Chen, Zhuyun Yan, Youping Liu
119 [GO] 2022―Nov―18 Identification of highly effective inhibitors against SARS-CoV-2 main protease: From virtual screening to in vitro study Hu Wang, Jun Wen, Yang Yang, Hailin Liu, Song Wang, Xiaoli Ding, et al. (+2)
120 [GO] 2022―Nov―17 Correlation between the severity of COVID-19 vaccine-related adverse events and the blood group of the vaccinees in Saudi Arabia: A web-based survey Ohoud S. Almalki, Amany S. Khalifa, Ozouf F. Alhemeidi, Ashraf A. Ewis, Abeer M. Shady, Sayed F. Abdelwahab
121 [GO] 2022―Nov―16 Immunopathogenesis in SARS-CoV-2 and Mycobacterium tuberculosis: The danger of overlapping crises Prakasini Satapathy, Radha Kanta Ratho, Sunil Sethi
122 [GO] 2022―Nov―14 Patterns of statin adherence in primary cardiovascular disease prevention during the pandemic Sara Malo, Lina Maldonado, María José Rabanaque, Antonio Gimeno-Miguel, Sara Castel-Feced, María Jesús Lallana, Isabel Aguilar-Palacio
123 [GO] 2022―Nov―11 Fusion assays for screening of fusion inhibitors targeting SARS-CoV-2 entry and syncytia formation Shiu-Wan Chan
124 [GO] 2022―Nov―11 Review of preclinical data of PF-07304814 and its active metabolite derivatives against SARS-CoV-2 infection Wujun Chen, Yingchun Shao, Xiaojin Peng, Bing Liang, Jiazhen Xu, Dongming Xing
125 [GO] 2022―Nov―11 Design of novel disturbing peptides against ACE2 SARS-CoV-2 spike-binding region by computational approaches Sara Zareei, Saeed Pourmand, Massoud Amanlou
126 [GO] 2022―Nov―09 Multicenter, randomized controlled trial of traditional Japanese medicine, kakkonto with shosaikotokakikyosekko, for mild and moderate coronavirus disease patients Shin Takayama, Takao Namiki, Ryutaro Arita, Rie Ono, Akiko Kikuchi, Minoru Ohsawa, et al. (+15)
127 [GO] 2022―Nov―08 Emerging pneumonia-like illness “legionellosis” in Argentina in the COVID-19 era: Cause to panic? Ranjan K. Mohapatra, Ahmed Mahal, Venkataramana Kandi, L. V. Simhachalam Kutikuppala, Ashish K. Sarangi, Snehasish Mishra
128 [GO] 2022―Nov―08 The effect of Nigella sativa and vitamin D3 supplementation on the clinical outcome in COVID-19 patients: A randomized controlled clinical trial Shimaa A. Said, Alsayyed Abdulbaset, Amal A. El-Kholy, Osama Besckales, Nagwa A. Sabri
129 [GO] 2022―Nov―08 Combined effect of traditional Chinese herbal-based formulations Jing Si herbal tea and Jing Si nasal drop inhibits adhesion and transmission of SARS-CoV2 in diabetic SKH-1 mice Chien-Yi Chiang, Wei-Wen Kuo, Yu-Jung Lin, Chia-Hua Kuo, Cheng-Yen Shih, Pi-Yu Lin, et al. (+4)
130 [GO] 2022―Nov―07 Serious adverse reaction associated with the COVID-19 vaccines of BNT162b2, Ad26.COV2.S, and mRNA-1273: Gaining insight through the VAERS Ming-Ming Yan, Hui Zhao, Zi-Ran Li, Jun-Wei Chow, Qian Zhang, Yu-Peng Qi, et al. (+3)
131 [GO] 2022―Nov―03 Efficacy and safety of glycyrrhizic acid preparation treating comorbid liver injury in COVID-19: A systematic review Xu Liu, Xia Tian, Zhipeng Ma, Jiali Chen, Qingsong Huang, Peiyang Gao, Chuantao Zhang
132 [GO] 2022―Okt―26 Herbo-mineral formulation, Divya-Swasari-Vati averts SARS-CoV-2 pseudovirus entry into human alveolar epithelial cells by interfering with spike protein-ACE 2 interaction and IL-6/TNF-α /NF-κB signaling Acharya Balkrishna, Sudeep Goswami, Hoshiyar Singh, Vivek Gohel, Rishabh Dev, Swati Haldar, Anurag Varshney
133 [GO] 2022―Okt―20 Plant polysaccharides with anti-lung injury effects as a potential therapeutic strategy for COVID-19 Peng Huang, Jiahui Zhang, Wenqian Duan, Juying Jiao, Aijing Leng, Jialin Qu
134 [GO] 2022―Okt―19 Prevention and treatment of ventilator-associated pneumonia in COVID-19 Jiayi Deng, Fanglin Li, Ningjie Zhang, Yanjun Zhong
135 [GO] 2022―Okt―19 Biofunctional roles of estrogen in coronavirus disease 2019: Beyond a steroid hormone Zhong-Ping Wang, Mao Hua, Tai Jiu, Ri-Li Ge, Zhenzhong Bai
136 [GO] 2022―Okt―19 Dual-targeting cyclic peptides of receptor-binding domain (RBD) and main protease (Mpro) as potential drug leads for the treatment of SARS-CoV-2 infection Zhen Xu, Yunting Zou, Xi Gao, Miao-Miao Niu, Jindong Li, Lu Xue, Su Jiang
137 [GO] 2022―Okt―14 Efficacy and safety of baricitinib and tocilizumab in hospitalized patients with COVID-19: A comparison using systematic review and meta-analysis Jerin Jose Cherian, Madhavi Eerike, Bhavani Shankara Bagepally, Saibal Das, Samiran Panda
138 [GO] 2022―Okt―12 In vitro effect of Withania somnifera, AYUSH-64, and remdesivir on the activity of CYP-450 enzymes: Implications for possible herb-drug interactions in the management of COVID-19 Siva Swapna Kasarla, Swapnil P. Borse, Yashwant Kumar, Neha Sharma, Madhu Dikshit
139 [GO] 2022―Okt―10 The potential for traditional Chinese therapy in treating sleep disorders caused by COVID-19 through the cholinergic anti-inflammatory pathway Xiaoxia Xie, Nana Zhang, Jingya Fu, Zhenzhi Wang, Zirun Ye, Zhijun Liu
140 [GO] 2022―Okt―10 Drugs for the prevention and treatment of COVID-19 and its complications: An update on what we learned in the past 2 years Giuseppe Remuzzi, Stefano Schiaffino, Maria Gabriella Santoro, Garret A. FitzGerald, Gennaro Melino, Carlo Patrono
141 [GO] 2022―Okt―07 A retrospective study of Pupingqinghua prescription versus Lianhuaqingwen in Chinese participants infected with SARS-CoV-2 Omicron variants Yidan Dong, Wei Zhai, Bangjiang Fang, Chenyang Liu, Suyun Yuan, Youhua Wang, et al. (+15)
142 [GO] 2022―Okt―05 Chinese herbal prescriptions for COVID-19 management: Special reference to Taiwan Chingguan Yihau (NRICM101) Yi-Chang Su, Guan-Jhong Huang, Jaung-Geng Lin
143 [GO] 2022―Okt―05 Associations between the use of aspirin or other antiplatelet drugs and all-cause mortality among patients with COVID-19: A meta-analysis Wanting Su, He Miao, Zhaotian Guo, Qianhui Chen, Tao Huang, Renyu Ding
144 [GO] 2022―Okt―05 Screening of potential inhibitors targeting the main protease structure of SARS-CoV-2 via molecular docking Xinbo Yang, Xianrong Xing, Yirui Liu, Yuanjie Zheng
145 [GO] 2022―Okt―03 Maintained anxiolytic effects of cannabidiol after treatment discontinuation in healthcare workers during the COVID-19 pandemic José Diogo S. Souza, Antonio W. Zuardi, Francisco S. Guimarães, Flávia de Lima Osório, Sonia Regina Loureiro, Alline Cristina Campos, et al. (+17)
146 [GO] 2022―Okt―03 Theoretical exploration on structures, bonding aspects and molecular docking of α-aminophosphonate ligated copper complexes against SARS-CoV-2 proteases Oval Yadav, Manjeet Kumar, Himanshi Mittal, Kiran Yadav, Veronique Seidel, Azaj Ansari
147 [GO] 2022―Sep―30 Atovaquone for treatment of COVID-19: A prospective randomized, double-blind, placebo-controlled clinical trial Mamta K. Jain, James A. De Lemos, Darren K. McGuire, Colby. Ayers, Jennifer L. Eitson, Claudia L. Sanchez, et al. (+13)
148 [GO] 2022―Sep―29 Potential therapeutic strategies for quercetin targeting critical pathological mechanisms associated with colon adenocarcinoma and COVID-19 Xiushen Li, Weizheng Liang, Chengwei Yu, Qingxue Meng, Weiwen Zhang, Xueliang Wu, et al. (+3)
149 [GO] 2022―Sep―27 Hydroxychloroquine, azithromycin and methylprednisolone and in hospital survival in severe COVID-19 pneumonia Ronaldo C. Go, Themba Nyirenda
150 [GO] 2022―Sep―26 Warfarin anticoagulation management during the COVID-19 pandemic: The role of internet clinic and machine learning Meng-Fei Dai, Shu-Yue Li, Ji-Fan Zhang, Bao-Yan Wang, Lin Zhou, Feng Yu, et al. (+2)
151 [GO] 2022―Sep―26 Apolipoprotein-A-I for severe COVID-19-induced hyperinflammatory states: A prospective case study Stanislas Faguer, Arnaud Del Bello, Chloé Danet, Yves Renaudineau, Jacques Izopet, Nassim Kamar
152 [GO] 2022―Sep―23 Network pharmacology and computer-aided drug design to explored potential targets of Lianhua Qingwen and Qingfei Paidu decoction for COVID-19 Liyuan Li, Xiaoying Wang, Xiao Guo, Yikun Li, Qiuhang Song, Aiying Li
153 [GO] 2022―Sep―20 Willingness to pay for and willingness to vaccinate with the COVID-19 vaccine booster dose in China Hui Jun Zhou, Lei Pan, Hui Shi, Ji Wei Luo, Pei Wang, Hannah K. Porter, et al. (+2)
154 [GO] 2022―Sep―16 Erratum: Remdesivir strongly binds to RNA-dependent RNA polymerase, membrane protein, and main protease of SARS-CoV-2: Indication from molecular modeling and simulations Frontiers Production Office
155 [GO] 2022―Sep―14 International cohort study indicates no association between alpha-1 blockers and susceptibility to COVID-19 in benign prostatic hyperplasia patients Akihiko Nishimura, Junqing Xie, Kristin Kostka, Talita Duarte-Salles, Sergio Fernández Bertolín, María Aragón, et al. (+20)
156 [GO] 2022―Sep―13 Single-cell sequencing of brain tissues reveal the central nervous system’s susceptibility to SARS-CoV-2 and the drug Zhichao Lu, Ziheng Wang, Zhuhuan Song, Chen Chen, He Ma, Peipei Gong, Yunzhao Xu
157 [GO] 2022―Sep―09 Psychotropic drugs interaction with the lipid nanoparticle of COVID-19 mRNA therapeutics Adonis Sfera, Sabine Hazan, Jonathan J. Anton, Dan O. Sfera, Christina V. Andronescu, Sarvin Sasannia, et al. (+2)
158 [GO] 2022―Sep―09 Efficacy and safety of chinese herbal medicine for treating mild or moderate COVID-19: A systematic review and meta-analysis of randomized controlled trials and observational studies Hongfei Zhu, Mengting Li, Chen Tian, Honghao Lai, Yuqing Zhang, Jiaheng Shi, et al. (+8)
159 [GO] 2022―Sep―08 Remdesivir in treating hospitalized patients with COVID-19: A renewed review of clinical trials Zhenchao Wu, Zhifei Han, Beibei Liu, Ning Shen
160 [GO] 2022―Sep―07 Toll-like receptor (TLRs) agonists and antagonists for COVID-19 treatments Zhi-Mei Liu, Ming-Hui Yang, Kun Yu, Zheng-Xing Lian, Shou-Long Deng
161 [GO] 2022―Sep―06 Corrigendum: Impact of the COVID-19 pandemic on the diagnosis of tuberculosis in Brazil: Is the WHO end TB strategy at risk? Mariana do Rosário Souza, Wandklebson Silva da Paz, Vinícius Barbosa dos Santos Sales, Gleidson Felipe Hilario de Jesus, Débora dos Santos Tavares, Shirley V. M. Almeida Lima, et al. (+5)
162 [GO] 2022―Sep―06 A novel gene signature based on the hub genes of COVID-19 predicts the prognosis of idiopathic pulmonary fibrosis Run Guo, Yuefei Zhou, Fang Lin, Mengxing Li, Chunting Tan, Bo Xu
163 [GO] 2022―Sep―06 Randomized, placebo-controlled, single-blind phase 1 studies of the safety, tolerability, and pharmacokinetics of BRII-196 and BRII-198, SARS-CoV-2 spike-targeting monoclonal antibodies with an extended half-life in healthy adults Xiaohua Hao, Zheng Zhang, Ji Ma, Lin Cheng, Yun Ji, Yang Liu, et al. (+8)
164 [GO] 2022―Sep―02 Exploring the mechanism of action of licorice in the treatment of COVID-19 through bioinformatics analysis and molecular dynamics simulation Jun-Feng Cao, Yunli Gong, Mei Wu, Xingyu Yang, Li Xiong, Shengyan Chen, et al. (+5)
165 [GO] 2022―Sep―01 Therapeutic effects of herbal-medicine combined therapy for COVID-19: A systematic review and meta-analysis of randomized controlled trials Tsai-Ju Chien, Chia-Yu Liu, Yuan-I Chang, Ching-Ju Fang, Juo-Hsiang Pai, Yu-Xuan Wu, Shuoh-Wen Chen
166 [GO] 2022―Aug―26 Immune-related adverse events of biological immunotherapies used in COVID-19 Daniela Baracaldo-Santamaría, Giovanna María Barros-Arias, Felipe Hernández-Guerrero, Alejandra De-La-Torre, Carlos-Alberto Calderon-Ospina
167 [GO] 2022―Aug―25 Optimal COVID-19 therapeutic candidate discovery using the CANDO platform William Mangione, Zackary Falls, Ram Samudrala
168 [GO] 2022―Aug―25 Discovery of genistein derivatives as potential SARS-CoV-2 main protease inhibitors by virtual screening, molecular dynamics simulations and ADMET analysis Jiawei Liu, Ling Zhang, Jian Gao, Baochen Zhang, Xiaoli Liu, Ninghui Yang, et al. (+3)
169 [GO] 2022―Aug―24 Using an untargeted metabolomics approach to analyze serum metabolites in COVID-19 patients with nucleic acid turning negative Wenyu Chen, Ming Yao, Miaomiao Chen, Zhao Ou, Qi Yang, Yanbin He, et al. (+6)
170 [GO] 2022―Aug―19 Bioactive natural products in COVID-19 therapy Zhonglei Wang, Ning Wang, Liyan Yang, Xian-qing Song
171 [GO] 2022―Aug―19 A comprehensive review on disposition kinetics and dosage of oral administration of Andrographis paniculata, an alternative herbal medicine, in co-treatment of coronavirus disease Phanit Songvut, Tawit Suriyo, Duangchit Panomvana, Nuchanart Rangkadilok, Jutamaad Satayavivad
172 [GO] 2022―Aug―17 Investigation into the in vivo mechanism of diosmetin in patients with breast cancer and COVID-19 using bioinformatics Jin Wang, Shanbo Ma, Long Li, Yuhan Chen, Qian Yang, Feiyan Wang, et al. (+3)
173 [GO] 2022―Aug―16 Network pharmacology reveals multitarget mechanism of action of drugs to be repurposed for COVID-19 Melissa Alegría-Arcos, Tábata Barbosa, Felipe Sepúlveda, German Combariza, Janneth González, Carmen Gil, et al. (+2)
174 [GO] 2022―Aug―16 Preclinical Pharmacokinetics and In Vitro Properties of GS-441524, a Potential Oral Drug Candidate for COVID-19 Treatment Amy Q. Wang, Natalie R. Hagen, Elias C. Padilha, Mengbi Yang, Pranav Shah, Catherine Z. Chen, et al. (+5)
175 [GO] 2022―Aug―16 Effectiveness and safety analysis of SanHanHuaShi granules for the treatment of coronavirus disease 2019: Study protocol and statistical analysis plan for a randomized, parallel-controlled, open-label clinical trial Yangyang Liu, Xi Chen, Hongan Wang, Chensi Yao, Xiaowen Gou, Zezheng Gao, et al. (+15)
176 [GO] 2022―Aug―16 Real-world effectiveness of Yindan Jiedu granules-based treatment on patients infected with the SARS-CoV-2 Omicron variants BA.2 combined with high-risk factors: A cohort study Ying Feng, Yao Liu, Long Liu, Yao Liu, Yuyong Jiang, Yixin Hou, et al. (+4)
177 [GO] 2022―Aug―15 Authorization of COVID-19 clinical trials: lessons from 2 years of experience of a national competent authority Stéphane Vignot, Alban Dhanani, Isabelle Sainte-Marie, Laure de Ligniville Lajavardi, Gwennaelle Even, Muriel Echemann, et al. (+4)
178 [GO] 2022―Aug―15 Smart therapies against global pandemics: A potential of short peptides Vasso Apostolopoulos, Joanna Bojarska, Jack Feehan, John Matsoukas, Wojciech Wolf
179 [GO] 2022―Aug―11 Potential protective benefits of Schisandrin B against severe acute hepatitis in children during the COVID-19 pandemic based on a network pharmacology analysis Yanhua Fang, Lingling Zhang, Zhe Wang, Ruoyu Wang, Shanshan Liang
180 [GO] 2022―Aug―09 In silico analysis and preclinical findings uncover potential targets of anti-cervical carcinoma and COVID-19 in laminarin, a promising nutraceutical Jiaqi Liu, Yudong Chen, Litao Nie, Xiao Liang, Wenjun Huang, Rong Li
181 [GO] 2022―Aug―09 Editorial: Cytokine Release Syndrome in COVID-19: Mechanisms and Management Tao Hu
182 [GO] 2022―Aug―09 Structures of the SARS-CoV-2 spike glycoprotein and applications for novel drug development Xiao-Huan Liu, Ting Cheng, Bao-Yu Liu, Jia Chi, Ting Shu, Tao Wang
183 [GO] 2022―Aug―08 Role of tannic acid against SARS-cov-2 cell entry by targeting the interface region between S-protein-RBD and human ACE2 Xi Chen, Ziyuan Wang, Jing Wang, Yifan Yao, Qian Wang, Jiahao Huang, et al. (+8)
184 [GO] 2022―Aug―04 Application of network pharmacology in the study of the mechanism of action of traditional chinese medicine in the treatment of COVID-19 Shihao Zheng, Tianyu Xue, Bin Wang, Haolin Guo, Qiquan Liu
185 [GO] 2022―Aug―01 Identifying Drug-Induced Liver Injury Associated With Inflammation-Drug and Drug-Drug Interactions in Pharmacologic Treatments for COVID-19 by Bioinformatics and System Biology Analyses: The Role of Pregnane X Receptor Jingjing Huang, Zhaokang Zhang, Chenxia Hao, Yuzhen Qiu, Ruoming Tan, Jialin Liu, et al. (+3)
186 [GO] 2022―Jul―22 The common regulatory pathway of COVID-19 and multiple inflammatory diseases and the molecular mechanism of cepharanthine in the treatment of COVID-19 Ping Jiang, Jingyao Ye, Menglong Jia, Xiaopeng Li, Shujun Wei, Nianhu Li
187 [GO] 2022―Jul―22 Detecting drug-drug interactions between therapies for COVID-19 and concomitant medications through the FDA adverse event reporting system Eugene Jeong, Scott D. Nelson, Yu Su, Bradley Malin, Lang Li, You Chen
188 [GO] 2022―Jul―22 Treatment of COVID-19 Pneumonia and Acute Respiratory Distress With Ramatroban, a Thromboxane A2 and Prostaglandin D2 Receptor Antagonist: A Four-Patient Case Series Report Martin L. Ogletree, Kate Chander Chiang, Rashmi Kulshrestha, Aditya Agarwal, Ashutosh Agarwal, Ajay Gupta
189 [GO] 2022―Jul―22 Camostat Mesylate Versus Lopinavir/Ritonavir in Hospitalized Patients With COVID-19-Results From a Randomized, Controlled, Open Label, Platform Trial (ACOVACT) M. Karolyi, E. Pawelka, S. Omid, F. Koenig, V. Kauer, B. Rumpf, et al. (+15)
190 [GO] 2022―Jul―15 Role of Traditional Chinese Medicine in Treating Severe or Critical COVID-19: A Systematic Review of Randomized Controlled Trials and Observational Studies Mengting Li, Hongfei Zhu, Yafei Liu, Yao Lu, Minyao Sun, Yuqing Zhang, et al. (+8)
191 [GO] 2022―Jul―14 Use of Tox21 Screening Data to Evaluate the COVID-19 Drug Candidates for Their Potential Toxic Effects and Related Pathways Srilatha Sakamuru, Ruili Huang, Menghang Xia
192 [GO] 2022―Jul―13 Treatment Effect of Qingfei Paidu Decoction Combined With Conventional Treatment on COVID-19 Patients and Other Respiratory Diseases: A Multi-Center Retrospective Case Series Xingyu Zong, Ning Liang, Jingya Wang, Huizhen Li, Dingyi Wang, Yaxin Chen, et al. (+16)
193 [GO] 2022―Jul―13 A Case-Based Monitoring Approach to Evaluate Safety of COVID-19 Vaccines in a Partially Integrated Health Information System: A Study Protocol Norazida Ab Rahman, Ming Tsuey Lim, Fei Yee Lee, Su Miin Ong, Kalaiarasu M. Peariasamy, Sheamini Sivasampu
194 [GO] 2022―Jul―08 Editorial: Medication Safety in COVID-19 Management Saibal Das
195 [GO] 2022―Jul―08 Pre-Clinical Development of a Potent Neutralizing Antibody MW3321 With Extensive SARS-CoV-2 Variants Coverage Wen Jiang, Zherui Zhang, Yuhe Zhu, Ben Chen, Chunying Gu, Zhiyan Liu, et al. (+13)
196 [GO] 2022―Jul―07 Chronic Administration of COVID-19 Drugs Fluvoxamine and Lopinavir Shortens Action Potential Duration by Inhibiting the Human Ether-à-go-go-Related Gene and Cav1.2 Zequn Zheng, Dihui Cai, Yin Fu, Ying Wang, Yongfei Song, Jiangfang Lian
197 [GO] 2022―Jul―05 The Effect of Statins on Clinical Outcome Among Hospitalized Patients With COVID-19: A Multi-Centric Cohort Study Srikanth Umakanthan, Sanjum Senthil, Stanley John, Mahesh K. Madhavan, Jessica Das, Sonal Patil, et al. (+9)
198 [GO] 2022―Jul―04 Beneficial Effect of Short-Term Supplementation of High Dose of Vitamin D3 in Hospitalized Patients With COVID-19: A Multicenter, Single-Blinded, Prospective Randomized Pilot Clinical Trial Miguel Cervero, Daniel López-Wolf, Guiomar Casado, Maria Novella-Mena, Pablo Ryan-Murua, María Luisa Taboada-Martínez, et al. (+4)
199 [GO] 2022―Jul―04 Virofree, an Herbal Medicine-Based Formula, Interrupts the Viral Infection of Delta and Omicron Variants of SARS-CoV-2 Ly Hien Doan, Li-Wei Chu, Zi-Yi Huang, Anh Thuc Nguyen, Chia-Yin Lee, Chien-Ling Huang, et al. (+12)
200 [GO] 2022―Jun―30 The Anti-Histamine Azelastine, Identified by Computational Drug Repurposing, Inhibits Infection by Major Variants of SARS-CoV-2 in Cell Cultures and Reconstituted Human Nasal Tissue Robert Konrat, Henrietta Papp, Janine Kimpel, Annika Rössler, Valéria Szijártó, Gábor Nagy, et al. (+9)
201 [GO] 2022―Jun―30 Therapeutic Targeting of Innate Immune Receptors Against SARS-CoV-2 Infection Mariya Farooq, Abdul Waheed Khan, Bilal Ahmad, Moon Suk Kim, Sangdun Choi
202 [GO] 2022―Jun―29 Impact of the COVID-19 Pandemic on the Diagnosis of Tuberculosis in Brazil: Is the WHO End TB Strategy at Risk? Mariana do Rosário Souza, Wandklebson Silva da Paz, Vinícius Barbosa dos Santos Sales, Gleidson Felipe Hilario de Jesus, Débora dos Santos Tavares, Shirley V. M. Almeida Lima, et al. (+5)
203 [GO] 2022―Jun―24 Profiling COVID-19 Vaccine Adverse Events by Statistical and Ontological Analysis of VAERS Case Reports Wenxin Guo, Jessica Deguise, Yujia Tian, Philip Chi-En Huang, Rohit Goru, Qiuyue Yang, et al. (+5)
204 [GO] 2022―Jun―21 Is Ivermectin Effective in Treating COVID-19? Shuangshuang Yang, Shan Shen, Ning Hou
205 [GO] 2022―Jun―20 Herbal Medicine Intervention for the Treatment of COVID-19: A Living Systematic Review and Cumulative Meta-Analysis Lin Ang, Eunhye Song, Xiao-Yang Hu, Hye Won Lee, Yaolong Chen, Myeong Soo Lee
206 [GO] 2022―Jun―17 Target Specific Inhibition of Protein Tyrosine Kinase in Conjunction With Cancer and SARS-COV-2 by Olive Nutraceuticals Arabinda Ghosh, Nobendu Mukerjee, Bhavdeep Sharma, Anushree Pant, Yugal Kishore Mohanta, Rahul D. Jawarkar, et al. (+7)
207 [GO] 2022―Jun―15 Editorial: Pharmacological and Biochemical Perspectives of Kinase Inhibitors in Cancer and COVID-19 Therapeutics, Volume I Balakumar Chandrasekaran, Muthupandian Saravanan
208 [GO] 2022―Jun―08 Modeling Kaempferol as a Potential Pharmacological Agent for COVID-19/PF Co-Occurrence Based on Bioinformatics and System Pharmacological Tools Yong Jiang, Yi-Zi Xie, Chen-Wen Peng, Kai-Nan Yao, Xue-Ying Lin, Shao-Feng Zhan, et al. (+5)
209 [GO] 2022―Jun―07 Oral Co-Supplementation of Curcumin, Quercetin, and Vitamin D3 as an Adjuvant Therapy for Mild to Moderate Symptoms of COVID-19-Results From a Pilot Open-Label, Randomized Controlled Trial Amjad Khan, Somia Iqtadar, Sami Ullah Mumtaz, Michael Heinrich, Domingo A. Pascual-Figal, Shona Livingstone, Sajid Abaidullah
210 [GO] 2022―Jun―03 Efficacy and Safety of Chinese Medicine Lianhua Qingwen for Treating COVID-19: An Updated meta-Analysis Yapeng Li, Peng Xiao, Nanyang Liu, Zhijie Zhang
211 [GO] 2022―Jun―02 Bioinformatics and System Biology Approach to Reveal the Interaction Network and the Therapeutic Implications for Non-Small Cell Lung Cancer Patients With COVID-19 Zhenjie Zhuang, Xiaoying Zhong, Qianying Chen, Huiqi Chen, Zhanhua Liu
212 [GO] 2022―Jun―02 Chemical Constituents of Essential Oils Used in Olfactory Training: Focus on COVID-19 Induced Olfactory Dysfunction Sachiko Koyama, Thomas Heinbockel
213 [GO] 2022―Jun―02 Key Considerations for Phase 2 or 3 Clinical Study Design of Anti-Inflammatory Agent for COVID-19 Treatment Yewon Park, Joo Young Na, Joo-Youn Cho, Jaeseong Oh, Su-jin Rhee
214 [GO] 2022―Jun―01 Mechanism of Multi-Organ Injury in Experimental COVID-19 and Its Inhibition by a Small Molecule Peptide Michael J. Paidas, Natarajan Sampath, Emma A. Schindler, Daniela S. Cosio, Chima Obianuju Ndubizu, Nagarajarao Shamaladevi, et al. (+5)
215 [GO] 2022―Jun―01 p53/NF-kB Balance in SARS-CoV-2 Infection: From OMICs, Genomics and Pharmacogenomics Insights to Tailored Therapeutic Perspectives (COVIDomics) Daniela Milani, Lorenzo Caruso, Enrico Zauli, Adi Mohammed Al Owaifeer, Paola Secchiero, Giorgio Zauli, et al. (+2)
216 [GO] 2022―Mai―30 Initiation of Tocilizumab or Baricitinib Were Associated With Comparable Clinical Outcomes Among Patients Hospitalized With COVID-19 and Treated With Dexamethasone Carlos K. H. Wong, Kristy T. K. Lau, Ivan C. H. Au, Xi Xiong, Matthew S. H. Chung, Belle Y. C. Leung, et al. (+2)
217 [GO] 2022―Mai―23 Puerarin: A Potential Therapeutic for Colon Adenocarcinoma (COAD) Patients Suffering From SARS-CoV-2 Infection Weizheng Liang, Xiushen Li, Yue Yao, Qingxue Meng, Xueliang Wu, Hao Wang, Jun Xue
218 [GO] 2022―Mai―20 Exploiting Extracellular Vesicles Strategies to Modulate Cell Death and Inflammation in COVID-19 Barbara Bortot, Arianna Romani, Giuseppe Ricci, Stefania Biffi
219 [GO] 2022―Mai―20 COVID-19 Vaccine-Associated Transient Global Amnesia: A Disproportionality Analysis of the WHO Safety Database Diane Merino, Alexandre O. Gérard, Elise K. Van Obberghen, Nouha Ben Othman, Eric Ettore, Bruno Giordana, et al. (+5)
220 [GO] 2022―Mai―11 Long-Term Cardiovascular and Cerebrovascular Challenges Posed by COVID-19 in Patients With Familial Hypercholesterolemia Alpo Vuorio, Frederick Raal, Petra Ijäs, Markku Kaste, Petri T. Kovanen
221 [GO] 2022―Mai―02 Antiviral Activity of Selected Lamiaceae Essential Oils and Their Monoterpenes Against SARS-Cov-2 Sanja Ćavar Zeljković, Ermin Schadich, Petr Džubák, Marián Hajdúch, Petr Tarkowski
222 [GO] 2022―Apr―29 Oxidative Stress and Hyper-Inflammation as Major Drivers of Severe COVID-19 and Long COVID: Implications for the Benefit of High-Dose Intravenous Vitamin C Claudia Vollbracht, Karin Kraft
223 [GO] 2022―Apr―28 Network Pharmacology and Bioinformatics Analyses Identify Intersection Genes of Vitamin D3 and COVID-19 as Potential Therapeutic Targets Shanglin Wang, Huayu Gao, Xiaoru Wang, Xiaoli Ma, Lulu Zhang, Yuanxin Xing, et al. (+2)
224 [GO] 2022―Apr―27 Psychotropic Medication Use Before and During COVID-19: A Population-Wide Study Christine Leong, Kaarina Kowalec, Sherif Eltonsy, James M. Bolton, Murray W. Enns, Qier Tan, et al. (+8)
225 [GO] 2022―Apr―26 Echinacea Purpurea For the Long-Term Prevention of Viral Respiratory Tract Infections During Covid-19 Pandemic: A Randomized, Open, Controlled, Exploratory Clinical Study Emil Kolev, Lilyana Mircheva, Michael R. Edwards, Sebastian L. Johnston, Krassimir Kalinov, Rainer Stange, et al. (+3)
226 [GO] 2022―Apr―26 Selinexor and COVID-19: The Neglected Warden Gomaa Mostafa-Hedeab, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Nermeen N. Welson, Gaber El-Saber Batiha, Carlos Adam Conte-Junior
227 [GO] 2022―Apr―25 Effective Regulation of Gut Microbiota With Probiotics and Prebiotics May Prevent or Alleviate COVID-19 Through the Gut-Lung Axis Lei Xu, Chung S. Yang, Yanan Liu, Xin Zhang
228 [GO] 2022―Apr―25 Histamine Potentiates SARS-CoV-2 Spike Protein Entry Into Endothelial Cells Somasundaram Raghavan, M. Dennis Leo
229 [GO] 2022―Apr―14 Appropriateness of Antibiotic Prescriptions in Chinese Primary Health Care and the Impact of the COVID-19 Pandemic: A Typically Descriptive and Longitudinal Database Study in Yinchuan City Houyu Zhao, Shengfeng Wang, Ruogu Meng, Guozhen Liu, Jing Hu, Huina Zhang, et al. (+2)
230 [GO] 2022―Apr―14 Pharmaceutical Prospects of Curcuminoids for the Remedy of COVID-19: Truth or Myth Yaw-Syan Fu, Wan-Yi Ho, Ning Kang, May-Jywan Tsai, Jingyi Wu, Liyue Huang, Ching-Feng Weng
231 [GO] 2022―Apr―14 Efficacy and Safety of Lithium Treatment in SARS-CoV-2 Infected Patients Carlos Spuch, Marta López-García, Tania Rivera-Baltanás, J. J Cabrera-Alvargonzález, Sudhir Gadh, Daniela Rodrigues-Amorim, et al. (+15)
232 [GO] 2022―Apr―12 2-Deoxy-D-Glucose and its Derivatives for the COVID-19 Treatment: An Update Zoufang Huang, Vivek P. Chavda, Lalitkumar K. Vora, Normi Gajjar, Vasso Apostolopoulos, Nirav Shah, Zhe-Sheng Chen
233 [GO] 2022―Apr―07 Plant Source Derived Compound Exhibited In Silico Inhibition of Membrane Glycoprotein In SARS-CoV-2: Paving the Way to Discover a New Class of Compound For Treatment of COVID-19 Saurov Mahanta, Tufan Naiya, Kunal Biswas, Liza Changkakoti, Yugal Kishore Mohanta, Bhaben Tanti, et al. (+3)
234 [GO] 2022―Apr―07 Thymoquinone’s Antiviral Effects: It is Time to be Proven in the Covid-19 Pandemic Era and its Omicron Variant Surge Maen Abdelrahim, Abdullah Esmail, Noor Al Saadi, Eva Zsigmond, Ebtesam Al Najjar, Doaa Bugazia, et al. (+3)
235 [GO] 2022―Apr―05 Efficacy and Outcome of Remdesivir and Tocilizumab Combination Against Dexamethasone for the Treatment of Severe COVID-19: A Randomized Controlled Trial Abu Taiub Mohammed Mohiuddin Chowdhury, Aktar Kamal, Kafil Uddin Abbas, Shubhashis Talukder, Md Rezaul Karim, Md. Ahsan Ali, et al. (+3)
236 [GO] 2022―Apr―04 Kinase Inhibitors as Potential Therapeutic Agents in the Treatment of COVID-19 Rajashri R. Naik, Ashok K. Shakya, Safwan M. Aladwan, Mohamed El-Tanani
237 [GO] 2022―Mrz―31 The Use of Oral Anticoagulation Is Not Associated With a Reduced Risk of Mortality in Patients With COVID-19: A Systematic Review and Meta-Analysis of Cohort Studies Meng-Fei Dai, Si-Tong Guo, Yi-Jun Ke, Bao-Yan Wang, Feng Yu, Hang Xu, et al. (+2)
238 [GO] 2022―Mrz―30 Pulmonary Inflammatory Response in Lethal COVID-19 Reveals Potential Therapeutic Targets and Drugs in Phases III/IV Clinical Trials Andrés López-Cortés, Santiago Guerrero, Esteban Ortiz-Prado, Verónica Yumiceba, Antonella Vera-Guapi, Ángela León Cáceres, et al. (+23)
239 [GO] 2022―Mrz―30 Kampo Medicine Promotes Early Recovery From Coronavirus Disease 2019-Related Olfactory Dysfunction: A Retrospective Observational Study Rie Ono, Ryutaro Arita, Shin Takayama, Akiko Kikuchi, Minoru Ohsawa, Natsumi Saito, et al. (+2)
240 [GO] 2022―Mrz―30 In vitro Suppression of SARS-CoV-2 Infection by Existing Kampo Formulas and Crude Constituent Drugs Used for Treatment of Common Cold Respiratory Symptoms Masaki Kakimoto, Toshihito Nomura, Tanuza Nazmul, Hiroki Kitagawa, Keishi Kanno, Keiko Ogawa-Ochiai, et al. (+3)
241 [GO] 2022―Mrz―29 Treatment of COVID-19 in Hemodialysis Patients Using Traditional Chinese Medicine: A Single-Center, Retrospective Study Wei Huang, Bo Jiang, Jinli Luo, Meng Luo, Xiaoming Ding, Qian Yang, et al. (+3)
242 [GO] 2022―Mrz―29 Acute Kidney Injury Associated With Remdesivir: A Comprehensive Pharmacovigilance Analysis of COVID-19 Reports in FAERS Bin Wu, Min Luo, Fengbo Wu, Zhiyao He, Yuwen Li, Ting Xu
243 [GO] 2022―Mrz―29 Optimization of SARS-CoV-2 Pseudovirion Production in Lentivirus Backbone With a Novel Liposomal System Gokulnath Mahalingam, Hari Krishnareddy Rachamalla, Porkizhi Arjunan, Yogapriya Periyasami, Salma M, Saravanabhavan Thangavel, et al. (+5)
244 [GO] 2022―Mrz―29 Drug Prescriptions in the Outpatient Management of COVID-19: Evidence-Based Recommendations Versus Real Practice Valeria Belleudi, Marco Finocchietti, Filomena Fortinguerra, Aurora Di Filippo, Francesco Trotta, Marina Davoli, Antonio Addis
245 [GO] 2022―Mrz―29 Case Report: Recanalization of Branch Retinal Artery Occlusion Due to Microthrombi Following the First Dose of SARS-CoV-2 mRNA Vaccination Min Seung Kang, Sang Yoon Kim, Han Jo Kwon
246 [GO] 2022―Mrz―29 Honeysuckle (Lonicera japonica) and Huangqi (Astragalus membranaceus) Suppress SARS-CoV-2 Entry and COVID-19 Related Cytokine Storm in Vitro Yuan-Chieh Yeh, Ly Hien Doan, Zi-Yi Huang, Li-Wei Chu, Tzu-Hau Shi, Ying-Ray Lee, et al. (+8)
247 [GO] 2022―Mrz―24 Consumption Trends of Antibiotics in Brazil During the COVID-19 Pandemic Fernando de Sá Del Fiol, Cristiane de Cássia Bergamaschi, Isaltino Pereira De Andrade, Luciane Cruz Lopes, Marcus Tolentino Silva, Silvio Barberato-Filho
248 [GO] 2022―Mrz―23 The Traditional Chinese Medicine Formula Jing Guan Fang for Preventing SARS-CoV-2 Infection: From Clinical Observation to Basic Research Yueh-Hsin Ping, Hsin Yeh, Li-Wei Chu, Zhi-Hu Lin, Yin-Chieh Hsu, Lie-Chwen Lin, et al. (+3)
249 [GO] 2022―Mrz―22 Association Between Drug Treatments and the Incidence of Liver Injury in Hospitalized Patients With COVID-19 Suyu Gao, Qingqing Yang, Xuanxuan Wang, Wen Hu, Yun Lu, Kun Yang, et al. (+5)
250 [GO] 2022―Mrz―17 Acute Kidney Injury and Drugs Prescribed for COVID-19 in Diabetes Patients: A Real-World Disproportionality Analysis Yu Zhou, Jianbin Li, Linyao Wang, Xinyan Zhu, Meilian Zhang, Jiaping Zheng
251 [GO] 2022―Mrz―15 Editorial: Vitamin D and COVID-19: New Mechanistic and Therapeutic Insights Ewa Marcinkowska, Geoffrey Brown
252 [GO] 2022―Mrz―14 Editorial: Novel Therapeutic Interventions Against Infectious Diseases: COVID-19 Sugunadevi Sakkiah, Brijesh Kumar Singh, Keun Woo Lee, Chandrabose Selvaraj
253 [GO] 2022―Mrz―10 Riboflavin for COVID-19 Adjuvant Treatment in Patients With Mental Health Disorders: Observational Study R. A. Akasov, E. V. Khaydukov, D. S. Andreyuk, N. V. Sholina, A. N. Sheremeta, D. V. Romanov, et al. (+3)
254 [GO] 2022―Mrz―10 Aspirin in COVID-19: Pros and Cons Rana Zareef, Marwa Diab, Tala Al Saleh, Adham Makarem, Nour K. Younis, Fadi Bitar, Mariam Arabi
255 [GO] 2022―Mrz―10 Oral Lisinopril Raises Tissue Levels of ACE2, the SARS-CoV-2 Receptor, in Healthy Male and Female Mice Steven D. Brooks, Rachel L. Smith, Aline S. Moreira, Hans C. Ackerman
256 [GO] 2022―Mrz―09 Diabetes, Metformin and the Clinical Course of Covid-19: Outcomes, Mechanisms and Suggestions on the Therapeutic Use of Metformin Clifford J. Bailey, Mike Gwilt
257 [GO] 2022―Mrz―08 Inspiration for COVID-19 Treatment: Network Analysis and Experimental Validation of Baicalin for Cytokine Storm Jia You, Huawei Li, Peng Fan, Xi Yang, Yuanfeng Wei, Lingnan Zheng, et al. (+2)
258 [GO] 2022―Mrz―04 Title: Understanding a Low Vitamin D State in the Context of COVID-19 James Bernard Walsh, Daniel M. McCartney, Éamon Laird, Kevin McCarroll, Declan G. Byrne, Martin Healy, et al. (+3)
259 [GO] 2022―Mrz―03 Difficulty in Repurposing Selective Serotonin Reuptake Inhibitors and Other Antidepressants with Functional Inhibition of Acid Sphingomyelinase in COVID-19 Infection Pascal Le Corre, Gwenolé Loas
260 [GO] 2022―Feb―28 Case Report: Tackling Complement Hyperactivation With Eculizumab in Atypical Hemolytic Uremic Syndrome Triggered by COVID-19 Valentina Fanny Leone, Amantia Imeraj, Sara Gastoldi, Caterina Mele, Lucia Liguori, Carmelita Condemi, et al. (+3)
261 [GO] 2022―Feb―25 Mechanism of Action of Small-Molecule Agents in Ongoing Clinical Trials for SARS-CoV-2: A Review Lei Zhao, Song Li, Wu Zhong
262 [GO] 2022―Feb―21 The Role of Vitamin D in COVID-19 and the Impact of Pandemic Restrictions on Vitamin D Blood Content Agata Tomaszewska, Agnieszka Rustecka, Agnieszka Lipińska-Opałka, Rafal P. Piprek, Małgorzata Kloc, Bolesław Kalicki, Jacek Z. Kubiak
263 [GO] 2022―Feb―21 A Novel COVID-19-Related Drug Discovery Approach Based on Non-Equidimensional Data Clustering Bolin Chen, Yourui Han, Xuequn Shang, Shenggui Zhang
264 [GO] 2022―Feb―18 Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies Mohitosh Biswas, Nares Sawajan, Thanyada Rungrotmongkol, Kamonpan Sanachai, Maliheh Ershadian, Chonlaphat Sukasem
265 [GO] 2022―Feb―18 Tocilizumab and COVID-19: Timing of Administration and Efficacy Emna Abidi, Wasim S. El Nekidy, Eman Alefishat, Nadeem Rahman, Georg A. Petroianu, Rania El-Lababidi, Jihad Mallat
266 [GO] 2022―Feb―14 Antibiotic Use in China’s Public Healthcare Institutions During the COVID-19 Pandemic: An Analysis of Nationwide Procurement Data, 2018-2020 Ying Yang, Xin Geng, Xiaojun Liu, Xiaotong Wen, Ruonan Wu, Dan Cui, Zongfu Mao
267 [GO] 2022―Feb―14 Increased Circulating Cytokines Have a Role in COVID-19 Severity and Death With a More Pronounced Effect in Males: A Systematic Review and Meta-Analysis Huating Hu, Hudan Pan, Runze Li, Kancheng He, Han Zhang, Liang Liu
268 [GO] 2022―Feb―09 Effectiveness of Antiviral Therapy in Highly-Transmissible Variants of SARS-CoV-2: A Modeling and Simulation Study Verena Schöning, Charlotte Kern, Carlos Chaccour, Felix Hammann
269 [GO] 2022―Feb―08 Montelukast Inhibits Platelet Activation Induced by Plasma From COVID-19 Patients Marina Camera, Paola Canzano, Marta Brambilla, G. Enrico Rovati
270 [GO] 2022―Feb―07 Evidence Mapping of 23 Systematic Reviews of Traditional Chinese Medicine Combined With Western Medicine Approaches for COVID-19 Ting Zhang, Xuechao Li, Yamin Chen, Liang Zhao, Jinhui Tian, Junhua Zhang
271 [GO] 2022―Feb―04 Continuous Renal Replacement Therapy With oXiris Filter May Not be an Effective Resolution to Alleviate Cytokine Release Syndrome in Non-AKI Patients With Severe and Critical COVID-19 Kai Kang, Yunpeng Luo, Yang Gao, Jiannan Zhang, Changsong Wang, Dongsheng Fei, et al. (+12)
272 [GO] 2022―Feb―04 The Association Between Proton Pump Inhibitors and COVID-19 is Confounded by Hyperglycemia in a Population-Based Study Asher Shafrir, Ariel A. Benson, Lior H. Katz, Tiberiu Hershcovici, Menachem Bitan, Ora Paltiel, et al. (+3)
273 [GO] 2022―Feb―04 Composition, Clinical Efficiency, and Mechanism of NHC-Approved “Three Chinese Medicines and Three Chinese Recipes” for COVID-19 Treatment Ke-Yao Xia, Zeyuan Zhao, Taif Shah, Jing-Yi Wang, Zulqarnain Baloch
274 [GO] 2022―Feb―02 The Role of Cytochrome P450 Enzymes in COVID-19 Pathogenesis and Therapy Guyi Wang, Bing Xiao, Jiayi Deng, Linmei Gong, Yi Li, Jinxiu Li, Yanjun Zhong
275 [GO] 2022―Jan―28 PBPK Modelling of Dexamethasone in Patients With COVID-19 and Liver Disease Maiara Camotti Montanha, Nicolas Cottura, Michael Booth, Daryl Hodge, Fazila Bunglawala, Hannah Kinvig, et al. (+4)
276 [GO] 2022―Jan―28 Barriers and Enablers for Adherence to Antiretroviral Therapy Among People Living With HIV/AIDS in the Era of COVID-19: A Qualitative Study From Pakistan Ali Ahmed, Juman Abdulelah Dujaili, Musarat Jabeen, Malik Muhammad Umair, Lay-Hong Chuah, Furqan Khurshid Hashmi, et al. (+2)
277 [GO] 2022―Jan―28 Commentary: Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells Fedor Simko, Tomas Baka
278 [GO] 2022―Jan―25 Construction of the Enterococcal Strain Expressing Immunogenic Fragment of SARS-Cov-2 Virus Alexander Suvorov, Tatiana Gupalova, Yulia Desheva, Tatiana Kramskaya, Elena Bormotova, Irina Koroleva, et al. (+2)
279 [GO] 2022―Jan―21 Specific Interleukin-1 Inhibitors, Specific Interleukin-6 Inhibitors, and GM-CSF Blockades for COVID-19 (at the Edge of Sepsis): A Systematic Review Ying Wang, Kun Zhu, Rulin Dai, Rui Li, Miao Li, Xin Lv, Qian Yu
280 [GO] 2022―Jan―20 Bulbus Fritillariae Cirrhosae as a Respiratory Medicine: Is There a Potential Drug in the Treatment of COVID-19? Yunyun Quan, Li Li, Zhujun Yin, Shilong Chen, Jing Yi, Jirui Lang, et al. (+3)
281 [GO] 2022―Jan―19 Antidepressant and Antipsychotic Drugs Reduce Viral Infection by SARS-CoV-2 and Fluoxetine Shows Antiviral Activity Against the Novel Variants in vitro Senem Merve Fred, Suvi Kuivanen, Hasan Ugurlu, Plinio Cabrera Casarotto, Lev Levanov, Kalle Saksela, et al. (+2)
282 [GO] 2022―Jan―13 COVID-19 and Periodontitis: A Dangerous Association? Francisco Javier Silvestre, Cecilia Fabiana Márquez-Arrico
283 [GO] 2022―Jan―12 Editorial: Biomolecules Against Coronaviruses: Molecular Aspects, Multi-Omics and Systems Pharmacology Christophe Hano, Ilaria Peluso, Jen-Tsung Chen
284 [GO] 2022―Jan―12 The Role of Interleukin-8 in Lung Inflammation and Injury: Implications for the Management of COVID-19 and Hyperinflammatory Acute Respiratory Distress Syndrome Maria Candida Cesta, Mara Zippoli, Carolina Marsiglia, Elizabeth Marie Gavioli, Flavio Mantelli, Marcello Allegretti, Robert A. Balk
285 [GO] 2022―Jan―12 Angiotensin-Converting Enzyme Genotype-Specific Immune Response Contributes to the Susceptibility of COVID-19: A Nested Case-Control Study Pengyun Gong, Fanghua Mei, Ruili Li, Yuchen Wang, Weizheng Li, Kai Pan, et al. (+5)
286 [GO] 2022―Jan―06 Opioids in COVID-19: Two Sides of a Coin Camila Vantini Capasso Palamim, Matheus Negri Boschiero, Aléthea Guimarães Faria, Felipe Eduardo Valencise, Fernando Augusto Lima Marson
287 [GO] 2022―Jan―05 The Interaction Between Pulmonary Fibrosis and COVID-19 and the Application of Related Anti-Fibrotic Drugs Hao Shen, Nu Zhang, Yuqing Liu, Xuerong Yang, Yuanyuan He, Qi Li, et al. (+3)
288 [GO] 2022―Jan―05 Construction of the Enterococcal Strain Expressing Immunogenic Fragment of SARS-Cov-2 Virus Alexander Suvorov, Tatiana Gupalova, Yulia Desheva, Tatiana Kramskaya, Elena Bormotova, Irina Koroleva, et al. (+2)
289 [GO] 2022―Jan―04 Perception, Attitude, and Confidence of Physicians About Antimicrobial Resistance and Antimicrobial Prescribing Among COVID-19 Patients: A Cross-Sectional Study From Punjab, Pakistan Khezar Hayat, Zia Ul Mustafa, Muhammad Nabeel Ikram, Muhammad Ijaz-Ul-Haq, Irum Noor, Muhammad Fawad Rasool, et al. (+4)
290 [GO] 2021―Dez―24 Signaling Potential Therapeutic Herbal Medicine Prescription for Treating COVID-19 by Collaborative Filtering Fan Yang, Qi Zhang, Zhongshang Yuan, Saisai Teng, Lizhen Cui, Fuzhong Xue, Leyi Wei
291 [GO] 2021―Dez―23 Host Factor Interaction Networks Identified by Integrative Bioinformatics Analysis Reveals Therapeutic Implications in COPD Patients With COVID-19 Wenjiang Zheng, Ting Wang, Peng Wu, Qian Yan, Chengxin Liu, Hui Wu, et al. (+4)
292 [GO] 2021―Dez―23 Molecular and Clinical Aspects of COVID-19 Vaccines and Other Therapeutic Interventions Apropos Emerging Variants of Concern Khursheed Ul Islam, Thoraya Mohamed Elhassan A-Elgadir, Sarah Afaq, Tanveer Ahmad, Jawed Iqbal
293 [GO] 2021―Dez―22 Household Drug Stockpiling and Panic Buying of Drugs During the COVID-19 Pandemic: A Study From Jordan Sura Al Zoubi, Lobna Gharaibeh, Hatim M. Jaber, Zaha Al-Zoubi
294 [GO] 2021―Dez―17 Corrigendum: Antiviral and Immunomodulatory Effects of Pelargonium sidoides DC. Root Extract EPs® 7630 in SARS-CoV-2-Infected Human Lung Cells Jan Papies, Jackson Emanuel, Nicolas Heinemann, Žarko Kulić, Simon Schroeder, Beate Tenner, et al. (+3)
295 [GO] 2021―Dez―16 Low-Dose Fluvoxamine Modulates Endocytic Trafficking of SARS-CoV-2 Spike Protein: A Potential Mechanism for Anti-COVID-19 Protection by Antidepressants Oleg O. Glebov
296 [GO] 2021―Dez―10 Increased Use of Antibiotics in the Intensive Care Unit During Coronavirus Disease (COVID-19) Pandemic in a Brazilian Hospital Alice Ramos Oliveira Silva, Diamantino Ribeiro Salgado, Luis Phillipe Nagem Lopes, Débora Castanheira, Isabel Cristina Martins Emmerick, Elisangela Costa Lima
297 [GO] 2021―Dez―08 Development of a Network-Based Signal Detection Tool: The COVID-19 Adversome in the FDA Adverse Event Reporting System Michele Fusaroli, Emanuel Raschi, Milo Gatti, Fabrizio De Ponti, Elisabetta Poluzzi
298 [GO] 2021―Dez―06 Pre-Steady-State Kinetics of the SARS-CoV-2 Main Protease as a Powerful Tool for Antiviral Drug Discovery Maria Yu. Zakharova, Alexandra A. Kuznetsova, Victoria I. Uvarova, Anastasiia D. Fomina, Liubov I. Kozlovskaya, Elena N. Kaliberda, et al. (+11)
299 [GO] 2021―Dez―03 Editorial: Ethnopharmacological Responses to the Coronavirus Disease 2019 Pandemic Jia-bo Wang, Adolfo Andrade-Cetto, Javier Echeverria, Jon Wardle, Hung-Rong Yen, Michael Heinrich
300 [GO] 2021―Dez―01 Natural Products for the Prevention and Control of the COVID-19 Pandemic: Sustainable Bioresources Rajeev K. Singla, Xuefei He, Hitesh Chopra, Christos Tsagkaris, Li Shen, Mohammad Amjad Kamal, Bairong Shen
301 [GO] 2021―Dez―01 Traditional Uses, Pharmacological Effects, and Molecular Mechanisms of Licorice in Potential Therapy of COVID-19 Qian-hui Zhang, Hao-zhou Huang, Min Qiu, Zhen-feng Wu, Zhan-chang Xin, Xin-fu Cai, et al. (+4)
302 [GO] 2021―Nov―22 Recent Updates in Experimental Research and Clinical Evaluation on Drugs for COVID-19 Treatment Houwen Zou, Yuqi Yang, Huiqiang Dai, Yunchuang Xiong, Jing-Quan Wang, Lusheng Lin, Zhe-Sheng Chen
303 [GO] 2021―Nov―19 Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells Oghenemega Okoloko, Elizabeth R. Vanderwall, Lucille M. Rich, Maria P. White, Stephen R. Reeves, Whitney E. Harrington, et al. (+2)
304 [GO] 2021―Nov―18 The Drug Repurposing for COVID-19 Clinical Trials Provide Very Effective Therapeutic Combinations: Lessons Learned From Major Clinical Studies Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, Govindasamy Agoramoorthy, Sang-Soo Lee
305 [GO] 2021―Nov―18 Immunological and Preventive Effects of Hochuekkito and Kakkonto Against Coronavirus Disease in Healthcare Workers: A Retrospective Observational Study Keiko Ogawa-Ochiai, Hideki Ishikawa, Hongyang Li, Lam Vu Quang, Izumi Kimoto, Mitsuyuki Takamura, et al. (+7)
306 [GO] 2021―Nov―11 Herb-Drug Interaction Between Xiyanping Injection and Lopinavir/Ritonavir, Two Agents Used in COVID-19 Pharmacotherapy Linhu Ye, Lei Cheng, Yan Deng, Hong Liu, Xinyu Wu, Tingting Wang, et al. (+5)
307 [GO] 2021―Nov―11 Screening of a Small Molecule Compound Library Identifies Toosendanin as an Inhibitor Against Bunyavirus and SARS-CoV-2 Shufen Li, Meidi Ye, Yuanqiao Chen, Yulan Zhang, Jiachen Li, Wei Liu, et al. (+2)
308 [GO] 2021―Nov―08 A Review of Medicinal Plants with Antiviral Activity Available in Bangladesh and Mechanistic Insight Into Their Bioactive Metabolites on SARS-CoV-2, HIV and HBV Sitesh C. Bachar, Kishor Mazumder, Ritesh Bachar, Asma Aktar, Mamun Al Mahtab
309 [GO] 2021―Nov―08 Breaking Barriers Amid the Pandemic: The Status of Telehealth in Southeast Asia and its Potential as a Mode of Healthcare Delivery in the Philippines Aitana Dy Macariola, Theara Mae Capacion Santarin, Ferianne Joy Manday Villaflor, Leofe Marie Guintos Villaluna, Rea Shane Leonora Yonzon, Jamie Ledesma Fermin, et al. (+4)
310 [GO] 2021―Nov―04 Phillyrin for COVID-19 and Influenza Co-infection: A Potential Therapeutic Strategy Targeting Host Based on Bioinformatics Analysis Yanni Lai, Tiantian Han, Zizhao Lao, Geng Li, Jianyong Xiao, Xiaohong Liu
311 [GO] 2021―Nov―02 Commentary: Potential Mechanism Prediction of Herbal Medicine for Pulmonary Fibrosis Associated With SARS-CoV-2 Infection Based on Network Analysis and Molecular Docking Congchao Jia, Xinya Peng, Hao Chi, Gang Tian
312 [GO] 2021―Okt―26 Traditional Chinese Medicine, Qingfei Paidu Decoction and Xuanfei Baidu Decoction, Inhibited Cytokine Production via NF-κB Signaling Pathway in Macrophages: Implications for Coronavirus Disease 2019 (COVID-19) Therapy Yujia Li, Bin Li, Pan Wang, Qinghua Wang
313 [GO] 2021―Okt―25 Clinical Characteristics and Inflammatory Immune Responses in COVID-19 Patients With Hypertension: A Retrospective Study Chaoran Wu, Guangbo Qu, Lei Wang, Shiyu Cao, Dandan Xia, Baolong Wang, et al. (+2)
314 [GO] 2021―Okt―25 Enteric Coronavirus Infection and Treatment Modeled With an Immunocompetent Human Intestine-On-A-Chip Amir Bein, Seongmin Kim, Girija Goyal, Wuji Cao, Cicely Fadel, Arash Naziripour, et al. (+17)
315 [GO] 2021―Okt―25 Corrigendum: Potential Mechanisms of Action of Chinese Patent Medicines for COVID-19: A Review Zhi-Hua Yang, Bin Wang, Qian Ma, Lin Wang, Ya-Xin Lin, Hai-Feng Yan, et al. (+8)
316 [GO] 2021―Okt―25 Antiviral and Immunomodulatory Effects of Pelargonium sidoides DC. Root Extract EPs® 7630 in SARS-CoV-2-Infected Human Lung Cells Jan Papies, Jackson Emanuel, Nicolas Heinemann, Žarko Kulić, Simon Schroeder, Beate Tenner, et al. (+3)
317 [GO] 2021―Okt―18 The Standard of Care Definitions on COVID-19 Pharmacological Clinical Trials: A Systematic Review Antonio Addis, Laura Amato, Fabio Cruciani, Rosella Saulle, Franco De Crescenzo, Zuzana Mitrova, et al. (+3)
318 [GO] 2021―Okt―14 Effect of Prophylactic Use of Intranasal Oil Formulations in the Hamster Model of COVID-19 Zaigham Abbas Rizvi, Manas Ranjan Tripathy, Nishant Sharma, Sandeep Goswami, N Srikanth, J. L. N. Sastry, et al. (+4)
319 [GO] 2021―Okt―01 The Establishment and Practice of Pharmacy Care Service Based on Internet Social Media: Telemedicine in Response to the COVID-19 Pandemic Huibo Li, Siqian Zheng, Da Li, Dechun Jiang, Fang Liu, Wei Guo, et al. (+4)
320 [GO] 2021―Sep―17 Immunotherapy Summary for Cytokine Storm in COVID-19 Yaqun Li, Wenjie Zhao, Jinhua Liu, Zichao Chen, Qingtao Lv, Zhen Zhang
321 [GO] 2021―Sep―15 Add-On Effect of Honeysuckle in the Treatment of Coronavirus Disease 2019: A Systematic Review and Meta-Analysis Xu-Qin Du, Li-Peng Shi, Wen-Fu Cao, Zhi-Wei Chen, Biao Zuo, Jin-Yuan Hu
322 [GO] 2021―Sep―09 Therapeutic Potential of Annexins in Sepsis and COVID-19 Louise Mui, Claudio M. Martin, Brent J. Tschirhart, Qingping Feng
323 [GO] 2021―Sep―09 Tele-pharmacy Anticoagulation Clinic During COVID-19 Pandemic: Patient Outcomes Maha Al Ammari, Khalefa AlThiab, Manal AlJohani, Khizra Sultana, Nada Maklhafi, Hayel AlOnazi, Aswaq Maringa
324 [GO] 2021―Sep―06 Yisaipu® Provide AS Patients With an Economical Therapeutic Option While Original Biologicals are More Advantageous in the COVID-19 Epidemic Situation Hongjuan Lu, Yuanqiong Wang, Xiuwen Wang, Xin Wu, Ling Zhou, Li Lin, et al. (+4)
325 [GO] 2021―Sep―06 Designing Short Peptides to Block the Interaction of SARS-CoV-2 and Human ACE2 for COVID-19 Therapeutics Abdul Basit, Asad Mustafa Karim, Muhammad Asif, Tanveer Ali, Jung Hun Lee, Jeong Ho Jeon, et al. (+2)
326 [GO] 2021―Sep―04 A Systematic Review and a Meta-Analysis Comparing Prophylactic and Therapeutic Low Molecular Weight Heparins for Mortality Reduction in 32,688 COVID-19 Patients Riccardo Giossi, Danilo Menichelli, Arianna Pani, Elena Tratta, Alessandra Romandini, Rossana Roncato, et al. (+7)
327 [GO] 2021―Sep―04 Favipiravir Versus Arbidol for Clinical Recovery Rate in Moderate and Severe Adult COVID-19 Patients: A Prospective, Multicenter, Open-Label, Randomized Controlled Clinical Trial Chang Chen, Yi Zhang, Jianying Huang, Ping Yin, Zhenshun Cheng, Jianyuan Wu, et al. (+8)
328 [GO] 2021―Sep―04 Clinical Progress on Management of Pneumonia Due to COVID-19 With Chinese Traditional Patent Medicines Ying Wu, Ping Zhong
329 [GO] 2021―Sep―04 Targeting of Protein’s Messenger RNA for Viral Replication, Assembly and Release in SARS-CoV-2 Using Whole Genomic Data From South Africa: Therapeutic Potentials of Cannabis Sativa L Ochuko L. Erukainure, Motlalepula G. Matsabisa, Aliyu Muhammad, Musa M. Abarshi, James F. Amaku, Sanusi B. Katsayal, Adeline Lum Nde
330 [GO] 2021―Sep―03 Identification of Novel Gene Signatures using Next-Generation Sequencing Data from COVID-19 Infection Models: Focus on Neuro-COVID and Potential Therapeutics Peter Natesan Pushparaj, Angham Abdulrahman Abdulkareem, Muhammad Imran Naseer
331 [GO] 2021―Aug―31 Kratom Use Within the Context of the Evolving Opioid Crisis and the COVID-19 Pandemic in the United States Walter C. Prozialeck, Peter C. Lamar, Michael Krupp, Matthew Moon, Laura E. Phelps, Oliver Grundmann
332 [GO] 2021―Aug―27 Ugonin J Acts as a SARS-CoV-2 3C-like Protease Inhibitor and Exhibits Anti-inflammatory Properties Wei-Chung Chiou, Hsu-Feng Lu, Nung-Yu Hsu, Tein-Yao Chang, Yuan-Fan Chin, Ping-Cheng Liu, et al. (+4)
333 [GO] 2021―Aug―24 Editorial: Drug Repurposing for COVID-19 Therapy Rafael Maldonado, Filippo Drago
334 [GO] 2021―Aug―23 mTOR-Inhibition and COVID-19 in Kidney Transplant Recipients: Focus on Pulmonary Fibrosis Simona Granata, Pierluigi Carraté, Giovanni Stallone, Gianluigi Zaza
335 [GO] 2021―Aug―18 Drug-Induced Liver Disturbance During the Treatment of COVID-19 Guanghua Zhai, Meifen Li, Ying Wang, Jian Wu
336 [GO] 2021―Aug―17 Natural Bioactive Molecules as Potential Agents Against SARS-CoV-2 Wei Chen, Zhihao Wang, Yawen Wang, Yiping Li
337 [GO] 2021―Aug―13 Remdesivir and Cyclosporine Synergistically Inhibit the Human Coronaviruses OC43 and SARS-CoV-2 Hsing-Yu Hsu, Cheng-Wei Yang, Yue-Zhi Lee, Yi-Ling Lin, Sui-Yuan Chang, Ruey-Bing Yang, et al. (+9)
338 [GO] 2021―Aug―12 Beneficial Treatment Outcomes of Severe COVID-19 Patients Treated Entirely in Primary Care Settings With Dexamethasone Including Regimen-Case Series Report Damir Vukoja, Andrea Jurić, Zdravka Erkapić, Tomislav Pejić, Željko Zovko, Josipa Juričić, et al. (+2)
339 [GO] 2021―Aug―12 Efficacy and Safety of Qingfei Paidu Decoction for Treating COVID-19: A Systematic Review and Meta-Analysis Qi Wang, Hongfei Zhu, Mengting Li, Yafei Liu, Honghao Lai, Qiuyu Yang, et al. (+2)
340 [GO] 2021―Aug―11 A Birds-Eye (Re)View of Acid-Suppression Drugs, COVID-19, and the Highly Variable Literature Cameron Mura, Saskia Preissner, Robert Preissner, Philip E. Bourne
341 [GO] 2021―Aug―09 Case Report: Can Inhaled Adenosine Attenuate COVID-19? Bruce D. Spiess, Michael Sitkovsky, Pierpaolo Correale, Nikolaus Gravenstein, Cynthia Garvan, Timothy E. Morey, et al. (+7)
342 [GO] 2021―Aug―06 Efficacy and Safety of Traditional Chinese Medicine in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis Heping Wang, Bowen Xu, Ying Zhang, Yuanyuan Duan, Ruike Gao, Haoqiang He, et al. (+2)
343 [GO] 2021―Aug―06 Heart Muscle Microphysiological System for Cardiac Liability Prediction of Repurposed COVID-19 Therapeutics Bérénice Charrez, Verena Charwat, Brian A. Siemons, Ishan Goswami, Courtney Sakolish, Yu-Syuan Luo, et al. (+5)
344 [GO] 2021―Aug―06 The Hyperlipidaemic Drug Fenofibrate Significantly Reduces Infection by SARS-CoV-2 in Cell Culture Models Scott P. Davies, Courtney J. Mycroft-West, Isabel Pagani, Harriet J. Hill, Yen-Hsi Chen, Richard Karlsson, et al. (+10)
345 [GO] 2021―Aug―05 NETosis and the Immune System in COVID-19: Mechanisms and Potential Treatments Constant Gillot, Julien Favresse, François Mullier, Thomas Lecompte, Jean-Michel Dogné, Jonathan Douxfils
346 [GO] 2021―Jul―28 Expert-Augmented Computational Drug Repurposing Identified Baricitinib as a Treatment for COVID-19 Daniel P. Smith, Olly Oechsle, Michael J. Rawling, Ed Savory, Alix M.B. Lacoste, Peter John Richardson
347 [GO] 2021―Jul―28 Ten Rules for Conducting Retrospective Pharmacoepidemiological Analyses: Example COVID-19 Study Michael Powell, Allison Koenecke, James Brian Byrd, Akihiko Nishimura, Maximilian F. Konig, Ruoxuan Xiong, et al. (+10)
348 [GO] 2021―Jul―20 Corrigendum: Therapeutic Potentials of Antiviral Plants Used in Traditional African Medicine With COVID-19 in Focus: A Nigerian Perspective Alfred Francis Attah, Adeshola Adebayo Fagbemi, Olujide Olubiyi, Hannah Dada-Adegbola, Akinseinde Oluwadotun, Anthony Elujoba, Chinedum Peace Babalola
349 [GO] 2021―Jul―20 Medicinal Plants Used for Treating Mild Covid-19 Symptoms Among Thai Karen and Hmong Methee Phumthum, Varangrat Nguanchoo, Henrik Balslev
350 [GO] 2021―Jul―16 The Role of High-Density Lipoprotein in COVID-19 Guyi Wang, Jiayi Deng, Jinxiu Li, Chenfang Wu, Haiyun Dong, Shangjie Wu, Yanjun Zhong
351 [GO] 2021―Jul―16 Potentials of Antitussive Traditional Persian Functional Foods for COVID-19 Therapy† Ghazaleh Mosleh, Parmis Badr, Meysam Zaeri, Abdolali Mohagheghzadeh
352 [GO] 2021―Jul―15 Potential Mechanisms of Action of Chinese Patent Medicines for COVID-19: A Review Zhi-Hua Yang, Bin Wang, Qian Ma, Lin Wang, Ya-Xin Lin, Hai-Feng Yan, et al. (+8)
353 [GO] 2021―Jul―09 Glycyrrhizic Acid: A Natural Plant Ingredient as a Drug Candidate to Treat COVID-19 Zhong Sun, Guozhong He, Ninghao Huang, Karuppiah Thilakavathy, Jonathan Chee Woei Lim, S. Suresh Kumar, Chenglong Xiong
354 [GO] 2021―Jul―08 Exploring Phytochemicals of Traditional Medicinal Plants Exhibiting Inhibitory Activity Against Main Protease, Spike Glycoprotein, RNA-dependent RNA Polymerase and Non-Structural Proteins of SARS-CoV-2 Through Virtual Screening Saranya Nallusamy, Jayakanthan Mannu, Caroline Ravikumar, Kandavelmani Angamuthu, Bharathi Nathan, Kumaravadivel Nachimuthu, et al. (+4)
355 [GO] 2021―Jul―07 Herbal Medicine, Gut Microbiota, and COVID-19 Ziqi Chen, Yiwen Lv, Huachong Xu, Li Deng
356 [GO] 2021―Jul―07 Remdesivir Strongly Binds to RNA-Dependent RNA Polymerase, Membrane Protein, and Main Protease of SARS-CoV-2: Indication From Molecular Modeling and Simulations Faez Iqbal Khan, Tongzhou Kang, Haider Ali, Dakun Lai
357 [GO] 2021―Jul―05 Targeting SARS-CoV-2-Platelet Interactions in COVID-19 and Vaccine-Related Thrombosis Dermot Cox
358 [GO] 2021―Jul―02 Efficacy and Safety of Leflunomide for Refractory COVID-19: A Pilot Study Qiang Wang, Haipeng Guo, Yu Li, Xiangdong Jian, Xinguo Hou, Ning Zhong, et al. (+14)
359 [GO] 2021―Jul―01 High Dose Lopinavir/Ritonavir Does Not Lead to Sufficient Plasma Levels to Inhibit SARS-CoV-2 in Hospitalized Patients With COVID-19 Mario Karolyi, Sara Omid, Erich Pawelka, Bernd Jilma, Thomas Stimpfl, Christian Schoergenhofer, et al. (+5)
360 [GO] 2021―Jul―01 Tocilizumab in COVID-19: Factors Associated With Mortality Before and After Treatment Luis Sarabia De Ardanaz, Jose M. Andreu-Ubero, Miriam Navidad-Fuentes, Miguel Ángel Ferrer-González, Victor Ruíz del Valle, Inmaculada Salcedo-Bellido, et al. (+3)
361 [GO] 2021―Jun―29 The Role of Pulmonary Surfactants in the Treatment of Acute Respiratory Distress Syndrome in COVID-19 Shengguang Wang, Zhen Li, Xinyu Wang, Shiming Zhang, Peng Gao, Zuorong Shi
362 [GO] 2021―Jun―29 Naturally Occurring Bioactives as Antivirals: Emphasis on Coronavirus Infection Seyed Abdulmajid Ayatollahi, Javad Sharifi-Rad, Patrick Valere Tsouh Fokou, Gail B. Mahady, Hafiz Ansar Rasul Suleria, Shivani Krishna Kapuganti, et al. (+9)
363 [GO] 2021―Jun―24 Serratiopeptidase, A Serine Protease Anti-Inflammatory, Fibrinolytic, and Mucolytic Drug, Can Be a Useful Adjuvant for Management in COVID-19 Charu Sharma, Niraj Kumar Jha, M. F. Nagoor Meeran, Chandragouda R. Patil, Sameer N. Goyal, Shreesh Ojha
364 [GO] 2021―Jun―23 Prevention and Recovery of COVID-19 Patients With Kampo Medicine: Review of Case Reports and Ongoing Clinical Trials Shin Takayama, Takao Namiki, Hiroshi Odaguchi, Ryutaro Arita, Akito Hisanaga, Kazuo Mitani, Takashi Ito
365 [GO] 2021―Jun―21 Overview of Viral Pneumonia Associated With Influenza Virus, Respiratory Syncytial Virus, and Coronavirus, and Therapeutics Based on Natural Products of Medicinal Plants Ziwei Hu, Jinhong Lin, Jintao Chen, Tengxi Cai, Lixin Xia, Ying Liu, et al. (+2)
366 [GO] 2021―Jun―18 He-Jie-Shen-Shi Decoction as an Adjuvant Therapy on Severe Coronavirus Disease 2019: A Retrospective Cohort and Potential Mechanistic Study Haibo Hu, Kun Wang, Li Wang, Yanjun Du, Juan Chen, Yongchun Li, et al. (+7)
367 [GO] 2021―Jun―17 The Impact of the Renin-Angiotensin-Aldosterone System on Inflammation, Coagulation, and Atherothrombotic Complications, and to Aggravated COVID-19 M. Ekholm, T. Kahan
368 [GO] 2021―Jun―17 Myricetin Inhibits SARS-CoV-2 Viral Replication by Targeting Mpro and Ameliorates Pulmonary Inflammation Ting Xiao, Mengqi Cui, Caijuan Zheng, Ming Wang, Ronghao Sun, Dandi Gao, et al. (+8)
369 [GO] 2021―Jun―16 Lactoferrin Against SARS-CoV-2: In Vitro and In Silico Evidences Elena Campione, Caterina Lanna, Terenzio Cosio, Luigi Rosa, Maria Pia Conte, Federico Iacovelli, et al. (+25)
370 [GO] 2021―Jun―14 A Repurposed Drug Screen Identifies Compounds That Inhibit the Binding of the COVID-19 Spike Protein to ACE2 Kaleb B. Tsegay, Christiana M. Adeyemi, Edward P. Gniffke, D. Noah Sather, John K. Walker, Stephen E. P. Smith
371 [GO] 2021―Jun―14 Therapeutic Effectiveness and Safety of Repurposing Drugs for the Treatment of COVID-19: Position Standing in 2021 Safaet Alam, Taslima Binte Kamal, Md. Moklesur Rahman Sarker, Jin-Rong Zhou, S. M. Abdur Rahman, Isa Naina Mohamed
372 [GO] 2021―Jun―11 A Dual-Route Perspective of SARS-CoV-2 Infection: Lung- vs. Gut-specific Effects of ACE-2 Deficiency Elizabeth M. Sajdel-Sulkowska
373 [GO] 2021―Jun―10 Glycyrrhizic Acid for COVID-19: Findings of Targeting Pivotal Inflammatory Pathways Triggered by SARS-CoV-2 Wenjiang Zheng, Xiufang Huang, Yanni Lai, Xiaohong Liu, Yong Jiang, Shaofeng Zhan
374 [GO] 2021―Jun―07 Therapeutic Targeting of Transcription Factors to Control the Cytokine Release Syndrome in COVID-19 Clarissa S. Santoso, Zhaorong Li, Jaice T. Rottenberg, Xing Liu, Vivian X. Shen, Juan I. Fuxman Bass
375 [GO] 2021―Jun―07 A Cross-Sectional Survey on Medication Management Practices for Noncommunicable Diseases in Europe During the Second Wave of the COVID-19 Pandemic Tamás Ágh, Job FM van Boven, Björn Wettermark, Enrica Menditto, Hilary Pinnock, Ioanna Tsiligianni, et al. (+4)
376 [GO] 2021―Jun―07 Pulmonary Edema in COVID-19 Patients: Mechanisms and Treatment Potential Xinyu Cui, Wuyue Chen, Haoyan Zhou, Yuan Gong, Bowen Zhu, Xiang Lv, et al. (+5)
377 [GO] 2021―Jun―04 The Role of Regional Anesthesia During the SARS-CoV2 Pandemic: Appraisal of Clinical, Pharmacological and Organizational Aspects Gianluca Cappelleri, Andrea Fanelli, Daniela Ghisi, Gianluca Russo, Antonio Giorgi, Vito Torrano, et al. (+3)
378 [GO] 2021―Jun―03 Adverse Effects Associated With the Use of Antimalarials During The COVID-19 Pandemic in a Tertiary Care Center in Mexico City Oscar Arturo Lozano-Cruz, José Víctor Jiménez, Antonio Olivas-Martinez, Edgar Ortiz-Brizuela, José Luis Cárdenas-Fragoso, Daniel Azamar-Llamas, et al. (+13)
379 [GO] 2021―Mai―28 Oral Curcumin With Piperine as Adjuvant Therapy for the Treatment of COVID-19: A Randomized Clinical Trial Kirti S Pawar, Rahul N Mastud, Satheesh K Pawar, Samragni S Pawar, Rahul R Bhoite, Ramesh R Bhoite, et al. (+2)
380 [GO] 2021―Mai―28 Traditional Herbal Medicines, Bioactive Metabolites, and Plant Products Against COVID-19: Update on Clinical Trials and Mechanism of Actions Safaet Alam, Md. Moklesur Rahman Sarker, Sadia Afrin, Fahmida Tasnim Richi, Chao Zhao, Jin-Rong Zhou, Isa Naina Mohamed
381 [GO] 2021―Mai―26 The Therapeutic Effect of Traditional Chinese Medicine on Inflammatory Diseases Caused by Virus, Especially on Those Caused by COVID-19 Peng Li, Shuang Hu, Cheng Qian, Yan Yao, Liang-yun Li, Jun-fa Yang, et al. (+10)
382 [GO] 2021―Mai―26 Systemic Corticosteroid Administration in Coronavirus Disease 2019 Outcomes: An Umbrella Meta-Analysis Incorporating Both Mild and Pulmonary Fibrosis-Manifested Severe Disease Bin Cheng, Jinxiu Ma, Yani Yang, Tingting Shao, Binghao Zhao, Linxiang Zeng
383 [GO] 2021―Mai―25 COVID-19-Associated Pneumonia: Radiobiological Insights Sabine François, Carole Helissey, Sophie Cavallero, Michel Drouet, Nicolas Libert, Jean-Marc Cosset, et al. (+3)
384 [GO] 2021―Mai―20 A Large Impact of Obesity on the Disposition of Ivermectin, Moxidectin and Eprinomectin in a Canine Model: Relevance for COVID-19 Patients Alain Bousquet-Mélou, Anne Lespine, Jean-François Sutra, Isabelle Bargues, Pierre-Louis Toutain
385 [GO] 2021―Mai―14 β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19 Niraj Kumar Jha, Charu Sharma, Hebaallah Mamdouh Hashiesh, Seenipandi Arunachalam, MF Nagoor Meeran, Hayate Javed, et al. (+3)
386 [GO] 2021―Mai―14 Broad Anti-Viral Capacities of Lian-Hua-Qing-Wen Capsule and Jin-Hua-Qing-Gan Granule and Rational use Against COVID-19 Based on Literature Mining Mingfei Shi, Bo Peng, An Li, Ziyun Li, Ping Song, Jing Li, et al. (+2)
387 [GO] 2021―Mai―13 Synergy Between Vitamin D and Sex Hormones in Respiratory Functionality of Patients Affected by COVID-19 Daniela Peruzzu, Maria Teresa Pagano, Marina Pierdominici, Anna Ruggieri, Andrea Antinori, Gianpiero D’Offizi, et al. (+11)
388 [GO] 2021―Mai―12 Multi-Omics Approach in the Identification of Potential Therapeutic Biomolecule for COVID-19 Rachana Singh, Pradhyumna Kumar Singh, Rajnish Kumar, Md. Tanvir Kabir, Mohammad Amjad Kamal, Abdur Rauf, et al. (+5)
389 [GO] 2021―Mai―07 Curcumin as a Potential Treatment for COVID-19 Bruna A. C. Rattis, Simone G. Ramos, Mara R. N. Celes
390 [GO] 2021―Mai―07 The Anti-Viral and Anti-Inflammatory Properties of Edible Bird’s Nest in Influenza and Coronavirus Infections: From Pre-Clinical to Potential Clinical Application Kien Hui Chua, Isa Naina Mohamed, Mohd Heikal Mohd Yunus, Norefrina Shafinaz Md Nor, Khidhir Kamil, Azizah Ugusman, Jaya Kumar
391 [GO] 2021―Mai―06 The Rise and Fall of Chloroquine/Hydroxychloroquine as Compassionate Therapy of COVID-19 Elangovan Manivannan, Chandrabose Karthikeyan, N. S. Hari Narayana Moorthy, Subash Chandra Chaturvedi
392 [GO] 2021―Mai―03 Withania somnifera (L.) Dunal: Opportunity for Clinical Repurposing in COVID-19 Management Akash Saggam, Kirti Limgaokar, Swapnil Borse, Preeti Chavan-Gautam, Santosh Dixit, Girish Tillu, Bhushan Patwardhan
393 [GO] 2021―Mai―03 A Survey Among Italian Physicians During COVID-19 Outbreak. Could Bacillus Calmette-Guérin Vaccine Be Effective Against SARS-CoV2? Vincenzo Patella, Alessandro Sanduzzi, Dario Bruzzese, Giovanni Florio, Raffaele Brancaccio, Gabriella Fabbrocini, Gabriele Delfino
394 [GO] 2021―Mai―03 Natural Products Modulating Angiotensin Converting Enzyme 2 (ACE2) as Potential COVID-19 Therapies Murtala Bello Abubakar, Dawoud Usman, Gaber El-Saber Batiha, Natália Cruz-Martins, Ibrahim Malami, Kasimu Ghandi Ibrahim, et al. (+10)
395 [GO] 2021―Mai―03 Comparative Effectiveness of Pharmacological Interventions for Covid-19: A Systematic Review and Network Meta-Analysis Franco De Crescenzo, Laura Amato, Fabio Cruciani, Luke P Moynihan, Gian Loreto D’Alò, Simona Vecchi, et al. (+5)
396 [GO] 2021―Apr―30 Intermittent Hypoxic Preconditioning: A Potential New Powerful Strategy for COVID-19 Rehabilitation Ming Cai, Xuan Chen, Jieling Shan, Ruoyu Yang, Qi Guo, Xia Bi, et al. (+4)
397 [GO] 2021―Apr―28 Edible and Herbal Plants for the Prevention and Management of COVID-19 Sha Li, Chien-Shan Cheng, Cheng Zhang, Guo-Yi Tang, Hor-Yue Tan, Hai-Yong Chen, et al. (+3)
398 [GO] 2021―Apr―26 Therapeutic Potentials of Antiviral Plants Used in Traditional African Medicine With COVID-19 in Focus: A Nigerian Perspective Alfred Francis Attah, Adeshola Adebayo Fagbemi, Olujide Olubiyi, Hannah Dada-Adegbola, Akinseinde Oluwadotun, Anthony Elujoba, Chinedum Peace Babalola
399 [GO] 2021―Apr―26 Phytochemicals as Potential Therapeutics for SARS-CoV-2-Induced Cardiovascular Complications: Thrombosis and Platelet Perspective Samir K. Beura, Abhishek R. Panigrahi, Pooja Yadav, Sunil K. Singh
400 [GO] 2021―Apr―23 Pleiotropic Effects of Tetracyclines in the Management of COVID-19: Emerging Perspectives Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Mohammed Alqarni, Natália Cruz-Martins, Gaber El-Saber Batiha
401 [GO] 2021―Apr―22 SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models G. Kanimozhi, B. Pradhapsingh, Charan Singh Pawar, Haseeb A. Khan, Salman H. Alrokayan, N. Rajendra Prasad
402 [GO] 2021―Apr―22 High Dose Intravenous Vitamin C for Preventing The Disease Aggravation of Moderate COVID-19 Pneumonia. A Retrospective Propensity Matched Before-After Study Bing Zhao, Min Liu, Ping Liu, Yibing Peng, Jun Huang, Mengjiao Li, et al. (+9)
403 [GO] 2021―Apr―22 No Efficacy of the Combination of Lopinavir/Ritonavir Plus Hydroxychloroquine Versus Standard of Care in Patients Hospitalized With COVID-19: A Non-Randomized Comparison Roberta Gagliardini, Alessandro Cozzi-Lepri, Andrea Mariano, Fabrizio Taglietti, Alessandra Vergori, Amina Abdeddaim, et al. (+15)
404 [GO] 2021―Apr―20 The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19 Annamaria Mascolo, Cristina Scavone, Concetta Rafaniello, Antonella De Angelis, Konrad Urbanek, Gabriella di Mauro, et al. (+4)
405 [GO] 2021―Apr―20 Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19 Vikas P. Sukhatme, Angela M. Reiersen, Sharat J. Vayttaden, Vidula V. Sukhatme
406 [GO] 2021―Apr―20 SARS-CoV-2 Switches ‘on’ MAPK and NFκB Signaling via the Reduction of Nuclear DUSP1 and DUSP5 Expression Swati Goel, Fatemeh Saheb Sharif-Askari, Narjes Saheb Sharif Askari, Bushra Madkhana, Ahmad Munzer Alwaa, Bassam Mahboub, et al. (+5)
407 [GO] 2021―Apr―19 Giloy Ghanvati (Tinospora cordifolia (Willd.) Hook. f. and Thomson) Reversed SARS-CoV-2 Viral Spike-Protein Induced Disease Phenotype in the Xenotransplant Model of Humanized Zebrafish Acharya Balkrishna, Lakshmipathi Khandrika, Anurag Varshney
408 [GO] 2021―Apr―16 Na+/K+-ATPase as a Target of Cardiac Glycosides for the Treatment of SARS-CoV-2 Infection Kauê Francisco Corrêa Souza e Souza, Bianca Portugal Tavares Moraes, Izabel Christina Nunes de Palmer Paixão, Patrícia Burth, Adriana Ribeiro Silva, Cassiano Felippe Gonçalves-de-Albuquerque
409 [GO] 2021―Apr―12 Evolving Treatment Paradigm in the Management of Diabetic Macular Edema in the Era of COVID-19 Claudio Iovino, Enrico Peiretti, Giuseppe Giannaccare, Vincenzo Scorcia, Adriano Carnevali
410 [GO] 2021―Apr―12 Commentary: Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated With Coronavirus Disease-2019 Maurizio Bifulco, Donatella Fiore, Chiara Piscopo, Patrizia Gazzerro, Maria Chiara Proto
411 [GO] 2021―Apr―12 Repurposing Chloroquine Against Multiple Diseases With Special Attention to SARS-CoV-2 and Associated Toxicity Siya Kamat, Madhuree Kumari
412 [GO] 2021―Apr―12 Potential Mechanism Prediction of Herbal Medicine for Pulmonary Fibrosis Associated with SARS-CoV-2 Infection Based on Network Analysis and Molecular Docking De Jin, Xuedong An, Yuqing Zhang, Shenghui Zhao, Liyun Duan, Yingying Duan, et al. (+2)
413 [GO] 2021―Apr―12 Phytoconstituents, In Vitro Anti-Infective Activity of Buddleja indica Lam., and In Silico Evaluation of its SARS-CoV-2 Inhibitory Potential Fadia S. Youssef, Ahmed E. Altyar, Abdelsattar M. Omar, Mohamed L. Ashour
414 [GO] 2021―Apr―01 Pathological Findings in COVID-19 as a Tool to Define SARS-CoV-2 Pathogenesis. A Systematic Review Cristina Mondello, Salvatore Roccuzzo, Orazio Malfa, Daniela Sapienza, Patrizia Gualniera, Elvira Ventura Spagnolo, et al. (+4)
415 [GO] 2021―Mrz―29 Angiotensin Receptor Blockers for COVID-19: Pathophysiological and Pharmacological Considerations About Ongoing and Future Prospective Clinical Trials Rodolfo Pedro Rothlin, Mariano Duarte, Facundo Germán Pelorosso, Liliana Nicolosi, M. Victoria Salgado, Héctor Miguel Vetulli, Eduardo Spitzer
416 [GO] 2021―Mrz―26 Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen Jordi Rodon, Jordana Muñoz-Basagoiti, Daniel Perez-Zsolt, Marc Noguera-Julian, Roger Paredes, Lourdes Mateu, et al. (+12)
417 [GO] 2021―Mrz―25 Head-to-Head Comparison of Sedation and Somnolence Among 37 Antipsychotics in Schizophrenia, Bipolar Disorder, Major Depression, Autism Spectrum Disorders, Delirium, and Repurposed in COVID-19, Infectious Diseases, and Oncology From the FAERS, 2004-2020 Andy R. Eugene, Beata Eugene, Marek Masiak, Jolanta Sylwia Masiak
418 [GO] 2021―Mrz―24 Medicinal Plants in COVID-19: Potential and Limitations Xin Yi Lim, Bee Ping Teh, Terence Yew Chin Tan
419 [GO] 2021―Mrz―23 COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms Robert W. Malone, Philip Tisdall, Philip Fremont-Smith, Yongfeng Liu, Xi-Ping Huang, Kris M. White, et al. (+19)
420 [GO] 2021―Mrz―23 Proactive Measures to Combat a SARS-CoV-2 Transmission Among High Risk Patients and Health Care Workers in an Outpatient Dialysis Facility Jayandiran Pillai, Pagollang Motloba, Keolebogile Shirley Caroline Motaung, Carole Wallis, Lovelyn Uzoma Ozougwu, Debashis Basu
421 [GO] 2021―Mrz―22 Comparing the Value of Cystatin C and Serum Creatinine for Evaluating the Renal Function and Predicting the Prognosis of COVID-19 Patients Sichao Chen, Jinpeng Li, Zeming Liu, Danyang Chen, Ling Zhou, Di Hu, et al. (+9)
422 [GO] 2021―Mrz―19 Repurposing Anti-Malaria Phytomedicine Artemisinin as a COVID-19 Drug Fatih M. Uckun, Saran Saund, Hitesh Windlass, Vuong Trieu
423 [GO] 2021―Mrz―15 Evaluation of the Current Therapeutic Approaches for COVID-19: A Systematic Review and a Meta-analysis Zeinab Abdelrahman, Qian Liu, Shanmei Jiang, Mengyuan Li, Qingrong Sun, Yue Zhang, Xiaosheng Wang
424 [GO] 2021―Mrz―10 Modeling of SARS-CoV-2 Treatment Effects for Informed Drug Repurposing Charlotte Kern, Verena Schöning, Carlos Chaccour, Felix Hammann
425 [GO] 2021―Mrz―09 Anti-IL5 Drugs in COVID-19 Patients: Role of Eosinophils in SARS-CoV-2-Induced Immunopathology Daniele Pala, Marco Pistis
426 [GO] 2021―Mrz―09 Plant Products as Inhibitors of Coronavirus 3CL Protease Anirban Mandal, Ajeet Kumar Jha, Banasri Hazra
427 [GO] 2021―Mrz―09 The Anti-inflammatory Effect of the Tricyclic Antidepressant Clomipramine and Its High Penetration in the Brain Might Be Useful to Prevent the Psychiatric Consequences of SARS-CoV-2 Infection B. Nobile, M. Durand, E. Olié, S. Guillaume, J. P. Molès, E. Haffen, P. Courtet
428 [GO] 2021―Mrz―08 An Update on Antiviral Therapy Against SARS-CoV-2: How Far Have We Come? Omkar Indari, Shweta Jakhmola, Elangovan Manivannan, Hem Chandra Jha
429 [GO] 2021―Mrz―04 1,2,3,4,6-Pentagalloyl Glucose, a RBD-ACE2 Binding Inhibitor to Prevent SARS-CoV-2 Infection Rui Hong Chen, Li Jun Yang, Sami Hamdoun, Sookja Kim Chung, Christopher Wai-kei Lam, Kai Xi Zhang, et al. (+4)
430 [GO] 2021―Mrz―02 Repurposing Treatment of Wernicke-Korsakoff Syndrome for Th-17 Cell Immune Storm Syndrome and Neurological Symptoms in COVID-19: Thiamine Efficacy and Safety, In-Vitro Evidence and Pharmacokinetic Profile Vatsalya Vatsalya, Fengyuan Li, Jane Frimodig, Khushboo S. Gala, Shweta Srivastava, Maiying Kong, et al. (+4)
431 [GO] 2021―Mrz―02 Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis Benedicto Crespo-Facorro, Miguel Ruiz-Veguilla, Javier Vázquez-Bourgon, Ana C. Sánchez-Hidalgo, Nathalia Garrido-Torres, Jose M. Cisneros, et al. (+2)
432 [GO] 2021―Mrz―02 Indian Medicinal Plants and Formulations and Their Potential Against COVID-19-Preclinical and Clinical Research Sayeed Ahmad, Sultan Zahiruddin, Bushra Parveen, Parakh Basist, Abida Parveen, Rabea Parveen, Minhaj Ahmad
433 [GO] 2021―Mrz―01 A Journey From SARS-CoV-2 to COVID-19 and Beyond: A Comprehensive Insight of Epidemiology, Diagnosis, Pathogenesis, and Overview of the Progress into Its Therapeutic Management Muhammad Harris Shoaib, Farrukh Rafiq Ahmed, Muhammad Sikandar, Rabia Ismail Yousuf, Muhammad Talha Saleem
434 [GO] 2021―Feb―26 In silico Analyses of Immune System Protein Interactome Network, Single-Cell RNA Sequencing of Human Tissues, and Artificial Neural Networks Reveal Potential Therapeutic Targets for Drug Repurposing Against COVID-19 Andrés López-Cortés, Patricia Guevara-Ramírez, Nikolaos C. Kyriakidis, Carlos Barba-Ostria, Ángela León Cáceres, Santiago Guerrero, et al. (+20)
435 [GO] 2021―Feb―26 A Scoping Insight on Potential Prophylactics, Vaccines and Therapeutic Weaponry for the Ongoing Novel Coronavirus (COVID-19) Pandemic- A Comprehensive Review Priyanka Dash, Subhashree Mohapatra, Sayantan Ghosh, Bismita Nayak
436 [GO] 2021―Feb―26 Chinese Herbal Medicine Used With or Without Conventional Western Therapy for COVID-19: An Evidence Review of Clinical Studies Shi-Bing Liang, Ying-Ying Zhang, Chen Shen, Chang-Hao Liang, Bao-Yong Lai, Ning Dai, et al. (+9)
437 [GO] 2021―Feb―26 Discovering Potential RNA Dependent RNA Polymerase Inhibitors as Prospective Drugs Against COVID-19: An in silico Approach Satabdi Saha, Rajat Nandi, Poonam Vishwakarma, Amresh Prakash, Diwakar Kumar
438 [GO] 2021―Feb―25 Prospective: Evolution of Chinese Medicine to Treat COVID-19 Patients in China Jieya Wu, Baoguo Sun, Li Hou, Fulan Guan, Liyuan Wang, Peikwen Cheng, et al. (+3)
439 [GO] 2021―Feb―23 The Potential Therapeutic Effect of RNA Interference and Natural Products on COVID-19: A Review of the Coronaviruses Infection Mohammad Reza Kalhori, Fatemeh Saadatpour, Ehsan Arefian, Masoud Soleimani, Mohammad Hosien Farzaei, Ina Yosifova Aneva, Javier Echeverría
440 [GO] 2021―Feb―22 Drug Repurposing and Polypharmacology to Fight SARS-CoV-2 Through Inhibition of the Main Protease Luca Pinzi, Annachiara Tinivella, Fabiana Caporuscio, Giulio Rastelli
441 [GO] 2021―Feb―13 Development of a Physiologically Based Pharmacokinetic Model for Hydroxychloroquine and Its Application in Dose Optimization in Specific COVID-19 Patients Miao Zhang, Xueting Yao, Zhe Hou, Xuan Guo, Siqi Tu, Zihan Lei, et al. (+10)
442 [GO] 2021―Feb―13 Molecular Mechanism of Action of Repurposed Drugs and Traditional Chinese Medicine Used for the Treatment of Patients Infected With COVID-19: A Systematic Scoping Review Fui Fui Lem, Fernandes Opook, Dexter Jiunn Herng Lee, Fong Tyng Chee, Fahcina P. Lawson, Su Na Chin
443 [GO] 2021―Feb―09 COVIEdb: A Database for Potential Immune Epitopes of Coronaviruses Jingcheng Wu, Wenfan Chen, Jingjing Zhou, Wenyi Zhao, Yisheng Sun, Hanping Zhu, et al. (+4)
444 [GO] 2021―Feb―08 Modalities and Mechanisms of Treatment for Coronavirus Disease 2019 Zhihong Zuo, Ting Wu, Liangyu Pan, Chenzhe Zuo, Yingchuo Hu, Xuan Luo, et al. (+6)
445 [GO] 2021―Feb―05 Yindan Jiedu Granules, a Traditional Chinese Medicinal Formulation, as a Potential Treatment for Coronavirus Disease 2019 Jingyuan Liu, Yuyong Jiang, Yao Liu, Lin Pu, Chunjing Du, Yuxin Li, et al. (+8)
446 [GO] 2021―Feb―05 Several FDA-Approved Drugs Effectively Inhibit SARS-CoV-2 Infection in vitro Hua-Long Xiong, Jia-Li Cao, Chen-Guang Shen, Jian Ma, Xiao-Yang Qiao, Tian-Shu Shi, et al. (+6)
447 [GO] 2021―Feb―04 Chemokine Regulation During Epidemic Coronavirus Infection Shamik Majumdar, Philip M. Murphy
448 [GO] 2021―Feb―01 Potency, Safety, and Pharmacokinetic Profiles of Potential Inhibitors Targeting SARS-CoV-2 Main Protease Hylemariam Mihiretie Mengist, Daniel Mekonnen, Ahmed Mohammed, Ronghua Shi, Tengchuan Jin
449 [GO] 2021―Jan―29 Mitochondria Are Potential Targets for the Development of New Drugs Against Neutrophilic Inflammation in Severe Pneumonia Including COVID-19 Nina V. Vorobjeva, Galina F. Sud'ina, Boris V. Chernyak
450 [GO] 2021―Jan―29 What Is the Difference Between Observed Association and Causal Association, Signals and Evidence? Examples Related to COVID-19 Vicki Osborne, Saad A. W. Shakir
451 [GO] 2021―Jan―29 HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons Andrey A. Poloznikov, Stepan A. Nersisyan, Dmitry M. Hushpulian, Eliot H. Kazakov, Alexander G. Tonevitsky, Sergey V. Kazakov, et al. (+4)
452 [GO] 2021―Jan―29 Perspectives of Antidiabetic Drugs in Diabetes With Coronavirus Infections Bao Sun, Shiqiong Huang, Jiecan Zhou
453 [GO] 2021―Jan―27 Calming the Storm: Natural Immunosuppressants as Adjuvants to Target the Cytokine Storm in COVID-19 Angela E. Peter, B. V. Sandeep, B. Ganga Rao, V. Lakshmi Kalpana
454 [GO] 2021―Jan―26 Potential of Immune-Related Therapy in COVID-19 Chunjue Yuan, Ruoyun Li, Guohong Liu, Yunbao Pan
455 [GO] 2021―Jan―26 Commentary: Paracetamol-Induced Glutathione Consumption: Is There a Link With Severe COVID-19 Illness? Sergio Verd, Mateo Verd
456 [GO] 2021―Jan―25 Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2 Catherine Z. Chen, Paul Shinn, Zina Itkin, Richard T. Eastman, Robert Bostwick, Lynn Rasmussen, et al. (+13)
457 [GO] 2021―Jan―20 Targeting Neurological Manifestations of Coronaviruses by Candidate Phytochemicals: A Mechanistic Approach Sajad Fakhri, Sana Piri, Mohammad Bagher Majnooni, Mohammad Hosein Farzaei, Javier Echeverría
458 [GO] 2021―Jan―19 Statins as Adjuvant Therapy for COVID-19 to Calm the Stormy Immunothrombosis and Beyond Alpo Vuorio, Petri T. Kovanen
459 [GO] 2021―Jan―15 Rapid Assessment of the Potential Paucity and Price Increases for Suggested Medicines and Protection Equipment for COVID-19 Across Developing Countries With a Particular Focus on Africa and the Implications Israel Abebrese Sefah, Olayinka O. Ogunleye, Darius Obeng Essah, Sylvia A. Opanga, Nadia Butt, Annie Wamaitha, et al. (+20)
460 [GO] 2021―Jan―15 Utilisation, Availability and Price Changes of Medicines and Protection Equipment for COVID-19 Among Selected Regions in India: Findings and Implications Mainul Haque, Santosh Kumar, Jaykaran Charan, Rohan Bhatt, Salequl Islam, Siddhartha Dutta, et al. (+6)
461 [GO] 2021―Jan―15 TLR9 and COVID-19: A Multidisciplinary Theory of a Multifaceted Therapeutic Target Gillina F. G. Bezemer, Johan Garssen
462 [GO] 2021―Jan―14 Methylene Blue Inhibits the SARS-CoV-2 Spike-ACE2 Protein-Protein Interaction-a Mechanism that can Contribute to its Antiviral Activity Against COVID-19 Damir Bojadzic, Oscar Alcazar, Peter Buchwald
463 [GO] 2021―Jan―14 3-Hydroxyphthalic Anhydride-Modified Chicken Ovalbumin as a Potential Candidate Inhibits SARS-CoV-2 Infection by Disrupting the Interaction of Spike Protein With Host ACE2 Receptor Taizhen Liang, Jiayin Qiu, Xiaoge Niu, Qinhai Ma, Chenliang Zhou, Pei Chen, et al. (+5)
464 [GO] 2021―Jan―14 Tissue Distribution of ACE2 Protein in Syrian Golden Hamster (Mesocricetus auratus) and Its Possible Implications in SARS-CoV-2 Related Studies Voddu Suresh, Deepti Parida, Aliva P. Minz, Manisha Sethi, Bhabani S. Sahoo, Shantibhusan Senapati
465 [GO] 2021―Jan―11 A Review on Plant Bioactive Compounds and Their Modes of Action Against Coronavirus Infection Juwairiah Remali, Wan Mohd Aizat
466 [GO] 2021―Jan―10 The Large Action of Chlorpromazine: Translational and Transdisciplinary Considerations in the Face of COVID-19 Emmanuel Stip, Tahir A. Rizvi, Farah Mustafa, Syed Javaid, Salahdein Aburuz, Nahida Nayaz Ahmed, et al. (+5)
467 [GO] 2021―Jan―10 Repurposing Approved Drugs for Guiding COVID-19 Prophylaxis: A Systematic Review Bruno Silva Andrade, Fernanda de Souza Rangel, Naiane Oliveira Santos, Andria dos Santos Freitas, Wagner Rodrigues de Assis Soares, Sérgio Siqueira, et al. (+4)
468 [GO] 2021―Jan―10 Current Evidence of Interleukin-6 Signaling Inhibitors in Patients With COVID-19: A Systematic Review and Meta-Analysis Qi Han, Mingyue Guo, Yue Zheng, Ying Zhang, Yanshan De, Changchang Xu, et al. (+7)
469 [GO] 2021―Jan―10 Commentary: Does Lithium Deserve a Place in the Treatment Against COVID-19? A Preliminary Observational Study in Six Patients, Case Report Christopher E. Rudd
470 [GO] 2021―Jan―07 Hydroxychloroquine as a Chemoprophylactic Agent for COVID-19: A Clinico-Pharmacological Review Mudit Agarwal, Piyush Ranjan, Upendra Baitha, Ankit Mittal
471 [GO] 2020―Dez―28 Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the Pandemic Giulio Cavalli, Nicola Farina, Corrado Campochiaro, Giacomo De Luca, Emanuel Della-Torre, Alessandro Tomelleri, Lorenzo Dagna
472 [GO] 2020―Dez―23 Case Report: Central Retinal Artery Occlusion in a COVID-19 Patient Andrea Montesel, Claudio Bucolo, Victoria Mouvet, Emmanuelle Moret, Chiara M. Eandi
473 [GO] 2020―Dez―21 D-Dimer as a Prognostic Indicator in Critically Ill Patients Hospitalized With COVID-19 in Leishenshan Hospital, Wuhan, China Jinpeng Li, Zeming Liu, Gaosong Wu, Meilin Yi, Yongfeng Chen, Kun Li, et al. (+5)
474 [GO] 2020―Dez―21 COVID-19 Incidence in Patients With Immunomediated Inflammatory Diseases: Influence of Immunosuppressant Treatments Natalia Soldevila-Domenech, Laura Tío, Jone Llorente-Onaindia, Elena Martín-García, Pau Nebot, Rafael de la Torre, et al. (+3)
475 [GO] 2020―Dez―18 COVID-19 Disease and Vitamin D: A Mini-Review Mohamed Said Boulkrane, Victoria Ilina, Roman Melchakov, Julia Fedotova, Filippo Drago, Lucia Gozzo, et al. (+3)
476 [GO] 2020―Dez―14 Inhibition of SARS-CoV-2 by Highly Potent Broad-Spectrum Anti-Coronaviral Tylophorine-Based Derivatives Cheng-Wei Yang, Yue-Zhi Lee, Hsing-Yu Hsu, Jia-Tsrong Jan, Yi-Ling Lin, Sui-Yuan Chang, et al. (+15)
477 [GO] 2020―Dez―14 A New Crystal Form of the SARS-CoV-2 Receptor Binding Domain: CR3022 Complex-An Ideal Target for In-Crystal Fragment Screening of the ACE2 Binding Site Surface Charlie Nichols, Joseph Ng, Annika Keshu, Franca Fraternali, Gian F. De Nicola
478 [GO] 2020―Dez―11 Alpha-1 Antitrypsin for COVID-19 Treatment: Dual Role in Antiviral Infection and Anti-Inflammation Chengliang Yang, Shaf Keshavjee, Mingyao Liu
479 [GO] 2020―Dez―11 Nutraceutical Targeting of Inflammation-Modulating microRNAs in Severe Forms of COVID-19: A Novel Approach to Prevent the Cytokine Storm Michel Desjarlais, Maëlle Wirth, Isabelle Lahaie, Pakiza Ruknudin, Pierre Hardy, Alain Rivard, Sylvain Chemtob
480 [GO] 2020―Dez―11 SARS-CoV-2 Spike-Heat Shock Protein A5 (GRP78) Recognition may be Related to the Immersed Human Coronaviruses Abdo A. Elfiky
481 [GO] 2020―Dez―10 Multidisciplinary Approach to the Diagnosis and In-Hospital Management of COVID-19 Infection: A Narrative Review Giuliano Lo Bianco, Santi Di Pietro, Emilia Mazzuca, Aurelio Imburgia, Luca Tarantino, Giuseppe Accurso, et al. (+5)
482 [GO] 2020―Dez―09 Prognostic Genetic Markers for Thrombosis in COVID-19 Patients: A Focused Analysis on D-Dimer, Homocysteine and Thromboembolism Mohamed Abu-Farha, Salman Al-Sabah, Maha M. Hammad, Prashantha Hebbar, Arshad Mohamed Channanath, Sumi Elsa John, et al. (+8)
483 [GO] 2020―Dez―07 Hydroxychloroquine in COVID-19 Patients: Pros and Cons Nour K. Younis, Rana O. Zareef, Sally N. Al Hassan, Fadi Bitar, Ali H. Eid, Mariam Arabi
484 [GO] 2020―Dez―03 Hydroxychloroquine as Prophylaxis for COVID-19: A Review Manuela Monti, Bernadette Vertogen, Carla Masini, Caterina Donati, Claudia Lilli, Chiara Zingaretti, et al. (+8)
485 [GO] 2020―Dez―03 Perspectives in Peptide-Based Vaccination Strategies for Syndrome Coronavirus 2 Pandemic Concetta Di Natale, Sara La Manna, Ilaria De Benedictis, Paola Brandi, Daniela Marasco
486 [GO] 2020―Nov―30 Dexamethasone Treatment for Covid-19, a Curious Precedent Highlighting a Regulatory Gap Lucia Gozzo, Laura Longo, Daniela Cristina Vitale, Filippo Drago
487 [GO] 2020―Nov―30 A Retrospective Study on the Use of Chinese Patent Medicine in 24 Medical Institutions for COVID-19 in China Nan Zhang, Nannan Shi, Siyu Li, Guoxiu Liu, Yonglong Han, Li Liu, et al. (+25)
488 [GO] 2020―Nov―30 Rationale for COVID-19 Treatment by Nebulized Interferon-β-1b-Literature Review and Personal Preliminary Experience Aurélien Mary, Lucie Hénaut, Pierre Yves Macq, Louise Badoux, Arnaud Cappe, Thierry Porée, et al. (+3)
489 [GO] 2020―Nov―26 Possible Role of Adenosine in COVID-19 Pathogenesis and Therapeutic Opportunities Jonathan D. Geiger, Nabab Khan, Madhuvika Murugan, Detlev Boison
490 [GO] 2020―Nov―26 Deciphering the Pharmacological Mechanisms of Ma Xing Shi Gan Decoction against COVID-19 through Integrating Network Pharmacology and Experimental Exploration Qianqian Li, Chen Bai, Ruocong Yang, Weiying Xing, Xiaohan Pang, Siying Wu, et al. (+4)
491 [GO] 2020―Nov―26 Severe Acute Respiratory Syndrome Coronavirus-2 Induces Cytokine Storm and Inflammation During Coronavirus Disease 19: Perspectives and Possible Therapeutic Approaches Federica Mannino, Alessandra Bitto, Natasha Irrera
492 [GO] 2020―Nov―25 An Evaluation of Traditional Persian Medicine for the Management of SARS-CoV-2 Roodabeh Bahramsoltani, Roja Rahimi
493 [GO] 2020―Nov―20 Neuronal and Cerebrovascular Complications in Coronavirus Disease 2019 Mudasir S. Andrabi, Shaida A. Andrabi
494 [GO] 2020―Nov―20 Rational Drug Repurposing: Focus on Lysosomotropism, Targets in Disease Process, Drug Profile, and Pulmonary Tissue Accumulation in SARS-CoV-2 Infection/COVID-19 Markus Blaess, Lars Kaiser, Oliver Sommerfeld, Simone Rentschler, René Csuk, Hans-Peter Deigner
495 [GO] 2020―Nov―19 Autophagy Modulation in Lymphocytes From COVID-19 Patients: New Therapeutic Target in SARS-COV-2 Infection Marta Vomero, Cristiana Barbati, Tania Colasanti, Alessandra Ida Celia, Mariangela Speziali, Federica Maria Ucci, et al. (+3)
496 [GO] 2020―Nov―18 Phytochemicals: Potential Therapeutic Interventions Against Coronavirus-Associated Lung Injury Mohammad Bagher Majnooni, Sajad Fakhri, Yalda Shokoohinia, Narges Kiyani, Katrina Stage, Pantea Mohammadi, et al. (+3)
497 [GO] 2020―Nov―17 A Review of Treatment of Coronavirus Disease 2019 (COVID-19): Therapeutic Repurposing and Unmet Clinical Needs Po-Lin Chen, Nan-Yao Lee, Cong-Tat Cia, Wen-Chien Ko, Po-Ren Hsueh
498 [GO] 2020―Nov―13 Computational Studies of Hydroxychloroquine and Chloroquine Metabolites as Possible Candidates for Coronavirus (COVID-19) Treatment Niteen A. Vaidya, Renu Vyas
499 [GO] 2020―Nov―09 Repurposing Sigma-1 Receptor Ligands for COVID-19 Therapy? José Miguel Vela
500 [GO] 2020―Nov―09 Potential Therapeutic Effect of Traditional Chinese Medicine on Coronavirus Disease 2019: A Review Qin Qiu, Yuge Huang, Xiaohua Liu, Fangfang Huang, Xiaoling Li, Liao Cui, et al. (+2)
501 [GO] 2020―Nov―06 Challenges for Drug Repurposing in the COVID-19 Pandemic Era Janet Sultana, Salvatore Crisafulli, Flic Gabbay, Elizabeth Lynn, Saad Shakir, Gianluca Trifirò
502 [GO] 2020―Nov―06 Celebrex Adjuvant Therapy on Coronavirus Disease 2019: An Experimental Study Wenxin Hong, Yan Chen, Kai You, Shenglin Tan, Feima Wu, Jiawang Tao, et al. (+12)
503 [GO] 2020―Nov―06 Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated with Coronavirus Disease-2019 Prakash Nagarkatti, Kathryn Miranda, Mitzi Nagarkatti
504 [GO] 2020―Okt―29 Targeting Macrophages as a Therapeutic Option in Coronavirus Disease 2019 Maria Gracia-Hernandez, Eduardo M. Sotomayor, Alejandro Villagra
505 [GO] 2020―Okt―29 Role of Endolysosomes in Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Coronavirus Disease 2019 Pathogenesis: Implications for Potential Treatments Nabab Khan, Xuesong Chen, Jonathan D. Geiger
506 [GO] 2020―Okt―28 Systematic Review and Pharmacological Considerations for Chloroquine and Its Analogs in the Treatment for COVID-19 Hongwei Peng, Zhangren Chen, Yunyun Wang, Simei Ren, Tiantian Xu, Xin Lai, et al. (+9)
507 [GO] 2020―Okt―28 Challenges in Repurposing Drugs in COVID-19 Pandemic. Debating on Potential New Refinements Giorgio Frega, Andrea Palloni, Giuseppe Di Pasquale, Gioconda Saccoccio, Alessandro Rizzo, Elisabetta Poluzzi, et al. (+2)
508 [GO] 2020―Okt―22 Prognostic Value of Pro-Inflammatory Neutrophils and C-Reactive Protein in Cancer Patient With Coronavirus Disease 2019: A Multi-Center, Retrospective Study Bo Zhang, Yuanhang Yu, Shawna Herbet, Yue Zhang, Jianhua Lu, Shihua Liu, et al. (+6)
509 [GO] 2020―Okt―22 Coronavirus-19: Possible Therapeutic Implications of Spironolactone and Dry Extract of Glycyrrhiza glabra L. (Licorice) Decio Armanini, Cristina Fiore, Jens Bielenberg, Chiara Sabbadin, Luciana Bordin
510 [GO] 2020―Okt―16 Tempering Macrophage Plasticity for Controlling SARS-CoV-2 Infection for Managing COVID-19 Disease Devinder Toor, Aklank Jain, Shivani Kalhan, Harmesh Manocha, Vivek Kumar Sharma, Payal Jain, et al. (+2)
511 [GO] 2020―Okt―16 COVID-19 Outbreak: Pathogenesis, Current Therapies, and Potentials for Future Management Md. Farhad Hossain, Sharifa Hasana, Abdullah Al Mamun, Md. Sahab Uddin, Mir Imam Ibne Wahed, Sabarni Sarker, et al. (+11)
512 [GO] 2020―Okt―16 Current Prevention of COVID-19: Natural Products and Herbal Medicine Junqing Huang, Gabriel Tao, Jingwen Liu, Junming Cai, Zhongyu Huang, Jia-xu Chen
513 [GO] 2020―Okt―15 Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients Fuxun Yang, Ruiming Yue, Xiaoxiu Luo, Rongan Liu, Xiaobo Huang
514 [GO] 2020―Okt―14 Vulnerabilities of the SARS-CoV-2 Virus to Proteotoxicity-Opportunity for Repurposed Chemotherapy of COVID-19 Infection Maryam S. Al-Motawa, Hafsa Abbas, Patrick Wijten, Alberto de la Fuente, Mingzhan Xue, Naila Rabbani, Paul J. Thornalley
515 [GO] 2020―Okt―09 Targeting Neutrophils to Treat Acute Respiratory Distress Syndrome in Coronavirus Disease Chih-Chao Chiang, Michal Korinek, Wei-Jen Cheng, Tsong-Long Hwang
516 [GO] 2020―Okt―08 Effect of Triple Combination Therapy With Lopinavir-Ritonavir, Azithromycin, and Hydroxychloroquine on QT Interval and Arrhythmic Risk in Hospitalized COVID-19 Patients Vincenzo Russo, Andreina Carbone, Filiberto Fausto Mottola, Rosa Mocerino, Raffaele Verde, Emilio Attena, et al. (+6)
517 [GO] 2020―Okt―08 “Fei Yan No. 1” as a Combined Treatment for COVID-19: An Efficacy and Potential Mechanistic Study Zhongzhu Ai, Shanshan Zhou, Weinan Li, Mengfan Wang, Linqun Wang, Gangming Hu, et al. (+7)
518 [GO] 2020―Okt―07 COVID-19 Genetic and Environmental Risk Factors: A Look at the Evidence Hana Abdelzaher, Basma M. Saleh, Hebatalla A. Ismail, Marwa Hafiz, Macy Abou Gabal, Miranda Mahmoud, et al. (+4)
519 [GO] 2020―Okt―07 Paracetamol-Induced Glutathione Consumption: Is There a Link With Severe COVID-19 Illness? Piero Sestili, Carmela Fimognari
520 [GO] 2020―Okt―07 Positive RT-PCR Test Results in 420 Patients Recovered From COVID-19 in Wuhan: An Observational Study Shaobin He, Jiaxing Tian, Xiaodong Li, Yana Zhou, Mingzhong Xiao, Ying Zhang, et al. (+19)
521 [GO] 2020―Okt―06 Available Compounds With Therapeutic Potential Against COVID-19: Antimicrobial Therapies, Supportive Care, and Probable Vaccines Rajnish Kumar, Janmejai Kumar Srivastava, Rachana Singh, Mohammed Haris Siddiqui, Rasha A. Mansouri, Jawaher A. Abdulhakim, et al. (+4)
522 [GO] 2020―Okt―02 Mapping Evidence of Pharmacy Services for COVID-19 in China Zhan-Miao Yi, Yang Hu, Guan-Ru Wang, Rong-Sheng Zhao
523 [GO] 2020―Sep―25 Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19) Surjeet Verma, Danielle Twilley, Tenille Esmear, Carel B. Oosthuizen, Anna-Mari Reid, Marizé Nel, Namrita Lall
524 [GO] 2020―Sep―25 The Important Role of Volatile Components From a Traditional Chinese Medicine Dayuan-Yin Against the COVID-19 Pandemic Xiao-rui Zhang, Ting-na Li, Yuan-yuan Ren, Yi-jia Zeng, Hong-yang Lv, Jin Wang, Qin-wan Huang
525 [GO] 2020―Sep―25 The Regulatory Challenges for Drug Repurposing During the Covid-19 Pandemic: The Italian Experience Lucia Gozzo, Laura Longo, Daniela Cristina Vitale, Filippo Drago
526 [GO] 2020―Sep―24 COVID-19: Is There Evidence for the Use of Herbal Medicines as Adjuvant Symptomatic Therapy? Dâmaris Silveira, Jose Maria Prieto-Garcia, Fabio Boylan, Omar Estrada, Yris Maria Fonseca-Bazzo, Claudia Masrouah Jamal, et al. (+4)
527 [GO] 2020―Sep―18 Efficacy of Early Combination Therapy With Lianhuaqingwen and Arbidol in Moderate and Severe COVID-19 Patients: A Retrospective Cohort Study Jie Fang, Hui Li, Wei Du, Ping Yu, Ying-Yun Guan, Shi-Yu Ma, et al. (+4)
528 [GO] 2020―Sep―17 Pathophysiology and Potential Therapeutic Candidates for COVID-19: A Poorly Understood Arena Arghadip Samaddar, Malika Grover, Vijaya Lakshmi Nag
529 [GO] 2020―Sep―16 In Silico Prediction of Molecular Targets of Astragaloside IV for Alleviation of COVID-19 Hyperinflammation by Systems Network Pharmacology and Bioinformatic Gene Expression Analysis Chenliang Ge, Yan He
530 [GO] 2020―Sep―16 Outcomes and Laboratory and Clinical Findings of Asthma and Allergic Patients Admitted With Covid-19 in a Spanish University Hospital Jesús Miguel García-Menaya, Concepción Cordobés-Durán, Juan Francisco Rangel-Mayoral, Elena García-Martín, José A. G. Agúndez
531 [GO] 2020―Sep―16 Use of Enoxaparin to Counteract COVID-19 Infection and Reduce Thromboembolic Venous Complications: A Review of the Current Evidence Filippo Drago, Lucia Gozzo, Li Li, Andrea Stella, Benilde Cosmi
532 [GO] 2020―Sep―15 Systems Pharmacology and Verification of ShenFuHuang Formula in Zebrafish Model Reveal Multi-Scale Treatment Strategy for Septic Syndrome in COVID-19 Tengwen Liu, Yuhong Guo, Jingxia Zhao, Shasha He, Yunjing Bai, Ning Wang, et al. (+3)
533 [GO] 2020―Sep―15 The Potential of Antiviral Peptides as COVID-19 Therapeutics Arun Suria Karnan Mahendran, Yin Sze Lim, Chee-Mun Fang, Hwei-San Loh, Cheng Foh Le
534 [GO] 2020―Sep―15 Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives Chandan Sarkar, Milon Mondal, Muhammad Torequl Islam, Miquel Martorell, Anca Oana Docea, Alfred Maroyi, et al. (+2)
535 [GO] 2020―Sep―11 Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future Olayinka O. Ogunleye, Debashis Basu, Debjani Mueller, Jacqueline Sneddon, R. Andrew Seaton, Adesola F. Yinka-Ogunleye, et al. (+66)
536 [GO] 2020―Sep―11 Research Progress on Main Symptoms of Novel Coronavirus Pneumonia Improved by Traditional Chinese Medicine Chuan-hong Luo, Le-le Ma, Hui-min Liu, Wei Liao, Run-chun Xu, Zhi-min Ci, et al. (+3)
537 [GO] 2020―Sep―10 Clinical Studies on the Treatment of Novel Coronavirus Pneumonia With Traditional Chinese Medicine-A Literature Analysis Zhihuan Zhou, Ning Gao, Yumeng Wang, Pengcheng Chang, Yi Tong, Shufei Fu
538 [GO] 2020―Sep―09 Age-Dependent Assessment of Genes Involved in Cellular Senescence, Telomere, and Mitochondrial Pathways in Human Lung Tissue of Smokers, COPD, and IPF: Associations With SARS-CoV-2 COVID-19 ACE2-TMPRSS2-Furin-DPP4 Axis Krishna P. Maremanda, Isaac K. Sundar, Dongmei Li, Irfan Rahman
539 [GO] 2020―Sep―09 Efficacy and Safety of Corticosteroid Treatment in Patients With COVID-19: A Systematic Review and Meta-Analysis Wenwen Cheng, Yufeng Li, Liyan Cui, Ying Chen, Sharui Shan, Duan Xiao, et al. (+3)
540 [GO] 2020―Sep―04 Montelukast Drug May Improve COVID-19 Prognosis: A Review of Evidence Jean Barré, Jean-Marc Sabatier, Cédric Annweiler
541 [GO] 2020―Sep―04 Potential Application of Drosophila melanogaster as a Model Organism in COVID-19-Related Research Firzan Nainu, Dini Rahmatika, Talha Bin Emran, Harapan Harapan
542 [GO] 2020―Sep―03 Skin Hyperpigmentation in Coronavirus Disease 2019 Patients: Is Polymyxin B the Culprit? Cuicui Lu, Ning Hou
543 [GO] 2020―Sep―02 Coronavirus Disease 2019 Related Clinical Studies: A Cross-Sectional Analysis Lin-Lu Ma, Xuan Yin, Bing-Hui Li, Jia-Yu Yang, Ying-Hui Jin, Di Huang, et al. (+5)
544 [GO] 2020―Aug―28 Immunosuppressive Drugs and COVID-19: A Review Tessa S. Schoot, Angèle P. M. Kerckhoffs, Luuk B. Hilbrands, Rob J. van Marum
545 [GO] 2020―Aug―28 Mitochondria Targeted Viral Replication and Survival Strategies-Prospective on SARS-CoV-2 Priya Gatti, Hema Saranya Ilamathi, Kiran Todkar, Marc Germain
546 [GO] 2020―Aug―27 Does Lithium Deserve a Place in the Treatment Against COVID-19? A Preliminary Observational Study in Six Patients, Case Report Carlos Spuch, Marta López-García, Tania Rivera-Baltanás, Daniela Rodrígues-Amorím, José M. Olivares
547 [GO] 2020―Aug―27 Quality Assessment of the Chinese Clinical Trial Protocols Regarding Treatments for Coronavirus Disease 2019 Jiaxing Zhang, Yiling Lu, Joey Sum-wing Kwong, Xiaosi Li, Wenyi Zheng, Rui He
548 [GO] 2020―Aug―27 Research Progress of Genetic Structure, Pathogenic Mechanism, Clinical Characteristics, and Potential Treatments of Coronavirus Disease 2019 Chunsheng Zhu, Bao Sun, Xiaochuan Zhang, Bing Zhang
549 [GO] 2020―Aug―26 SARS-CoV-2 Treatment Approaches: Numerous Options, No Certainty for a Versatile Virus Simona Iacob, Diana Gabriela Iacob
550 [GO] 2020―Aug―21 Evaluation of Remote Pharmacist-Led Outpatient Service for Geriatric Patients on Rivaroxaban for Nonvalvular Atrial Fibrillation During the COVID-19 Pandemic Xiaoye Li, Chengchun Zuo, Wenjing Lu, Ye Zou, Qing Xu, Xiaoyu Li, Qianzhou Lv
551 [GO] 2020―Aug―21 The Potential Role of Heparin in Patients With COVID-19: Beyond the Anticoagulant Effect. A Review Lucia Gozzo, Pierluigi Viale, Laura Longo, Daniela Cristina Vitale, Filippo Drago
552 [GO] 2020―Aug―20 Harnessing Memory NK Cell to Protect Against COVID-19 Saeede Soleimanian, Ramin Yaghobi
553 [GO] 2020―Aug―19 Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19 Rudra P. Saha, Ashish Ranjan Sharma, Manoj K. Singh, Saikat Samanta, Swarnav Bhakta, Snehasish Mandal, et al. (+3)
554 [GO] 2020―Aug―14 COVID-19 Usurps Host Regulatory Networks Colleen S. Curran, Donna R. Rivera, Jeffrey B. Kopp
555 [GO] 2020―Aug―13 A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes Colin D. Funk, Ali Ardakani
556 [GO] 2020―Aug―13 COVID-19 Therapeutic Options Under Investigation Malak Kaddoura, Malak AlIbrahim, Ghina Hijazi, Nadia Soudani, Amani Audi, Habib Alkalamouni, et al. (+3)
557 [GO] 2020―Aug―12 Corticosteroid Use in the Treatment of COVID-19: A Multicenter Retrospective Study in Hunan, China Yiming Ma, Huihui Zeng, Zijie Zhan, Huanhuan Lu, Zihang Zeng, Chenjie He, et al. (+13)
558 [GO] 2020―Aug―11 Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients Pasquale Paolisso, Luca Bergamaschi, Emanuela Concetta D’Angelo, Francesco Donati, Maddalena Giannella, Sara Tedeschi, et al. (+8)
559 [GO] 2020―Aug―07 Medicinal Plants as Sources of Active Molecules Against COVID-19 Bachir Benarba, Atanasio Pandiella
560 [GO] 2020―Aug―07 DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications? Inés Valencia, Concepción Peiró, Óscar Lorenzo, Carlos F. Sánchez-Ferrer, Jürgen Eckel, Tania Romacho
561 [GO] 2020―Aug―05 DPP-4 Inhibitors in the Prevention/Treatment of Pulmonary Fibrosis, Heart and Kidney Injury Caused by COVID-19-A Therapeutic Approach of Choice in Type 2 Diabetic Patients? Andrija Smelcerovic, Gordana Kocic, Mihajlo Gajic, Katarina Tomovic, Vukica Djordjevic, Dobrila Stankovic-Djordjevic, Marko Anderluh
562 [GO] 2020―Jul―31 Research Progress of Chloroquine and Hydroxychloroquine on the COVID-19 and Their Potential Risks in Clinic Use Yan Chen, TaiPeng Shen, LiJun Zhong, ZhiXi Liu, XinWei Dong, TingWenLi Huang, et al. (+2)
563 [GO] 2020―Jul―29 Cellular and Molecular Pathways of COVID-19 and Potential Points of Therapeutic Intervention John P. Hussman
564 [GO] 2020―Jul―29 Rationale for Considering Oral Idasanutlin as a Therapeutic Option for COVID-19 Patients Giorgio Zauli, Veronica Tisato, Paola Secchiero
565 [GO] 2020―Jul―17 Dynamic Interleukin-6 Level Changes as a Prognostic Indicator in Patients With COVID-19 Zeming Liu, Jinpeng Li, Danyang Chen, Rongfen Gao, Wen Zeng, Sichao Chen, et al. (+7)
566 [GO] 2020―Jul―17 Chinese Patent Medicines in the Treatment of Coronavirus Disease 2019 (COVID-19) in China Wei Zhuang, Zheng Fan, Yanqi Chu, Haizheng Wang, Ying Yang, Li Wu, et al. (+6)
567 [GO] 2020―Jul―16 The Folate Concentration and/or Folic Acid Metabolites in Plasma as Factor for COVID-19 Infection Jesus Acosta-Elias, Ricardo Espinosa-Tanguma
568 [GO] 2020―Jul―15 Selective Estrogen Receptor Modulators in COVID-19: A Possible Therapeutic Option? Alba Calderone, Francesco Menichetti, Ferruccio Santini, Luciano Colangelo, Ersilia Lucenteforte, Vincenzo Calderone
569 [GO] 2020―Jul―14 No Statistically Apparent Difference in Antiviral Effectiveness Observed Among Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha, and Ribavirin Plus Lopinavir/Ritonavir Plus Interferon-Alpha in Patients With Mild to Moderate Coronavirus Disease 2019: Results of a Randomized, Open-Labeled Prospective Study Yin-Qiu Huang, Sheng-Quan Tang, Xiao-Lei Xu, Yan-Ming Zeng, Xiao-Qing He, Yao Li, et al. (+9)
570 [GO] 2020―Jul―10 Pathological Aspects of COVID-19 as a Conformational Disease and the Use of Pharmacological Chaperones as a Potential Therapeutic Strategy Tomohiko Aoe
571 [GO] 2020―Jul―09 BCG Against SARS-CoV-2: Second Youth of an Old Age Vaccine? Siya Kamat, Madhuree Kumari
572 [GO] 2020―Jul―02 Turning the Tide: Natural Products and Natural-Product-Inspired Chemicals as Potential Counters to SARS-CoV-2 Infection Zhonglei Wang, Liyan Yang
573 [GO] 2020―Jun―24 Pharmacotherapics Advice in Guidelines for COVID-19 Zhang-Ren Chen, Ying Zhou, Jin Liu, Hong-Wei Peng, Jian Zhou, Hai-Li Zhong, et al. (+4)
574 [GO] 2020―Jun―24 Convalescent Plasma Coupled With Medications for the Treatment of a Severe COVID-19 Patient: Drugs Analysis and Pharmaceutical Care Based on the Newly Established Guidelines for COVID-19 Remedy Ying Wang, Yang Zhang, Qian Yu, Kun Zhu
575 [GO] 2020―Jun―19 Potential Benefits of Tryptophan Metabolism to the Efficacy of Tocilizumab in COVID-19 Maria Laura Belladonna, Ciriana Orabona
576 [GO] 2020―Jun―19 A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic Colin D. Funk, Craig Laferrière, Ali Ardakani
577 [GO] 2020―Jun―12 New Strategy for COVID-19: An Evolutionary Role for RGD Motif in SARS-CoV-2 and Potential Inhibitors for Virus Infection Shijia Yan, Haixia Sun, Xianzhang Bu, Guohui Wan
578 [GO] 2020―Jun―05 Repositioning Chromones for Early Anti-inflammatory Treatment of COVID-19 Piero Sestili, Vilberto Stocchi
579 [GO] 2020―Jun―05 Neutrophilia and NETopathy as Key Pathologic Drivers of Progressive Lung Impairment in Patients With COVID-19 Teluguakula Narasaraju, Benjamin M. Tang, Martin Herrmann, Sylviane Muller, Vincent T. K. Chow, Marko Radic
580 [GO] 2020―Jun―05 Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study Valentina Giudice, Pasquale Pagliano, Alessandro Vatrella, Alfonso Masullo, Sergio Poto, Benedetto Maria Polverino, et al. (+10)
581 [GO] 2020―Mai―29 An Open Question: Is It Rational to Inhibit the mTor-Dependent Pathway as COVID-19 Therapy? Giuseppe Terrazzano, Valentina Rubino, Anna Teresa Palatucci, Angela Giovazzino, Flavia Carriero, Giuseppina Ruggiero
582 [GO] 2020―Mai―26 Available Evidence and Ongoing Clinical Trials of Remdesivir: Could It Be a Promising Therapeutic Option for COVID-19? Mekonnen Sisay
583 [GO] 2020―Mai―26 Reducing the Fatality Rate of COVID-19 by Applying Clinical Insights From Immuno-Oncology and Lung Transplantation Fatih M. Uckun
584 [GO] 2020―Mai―01 The Zebrafish Disease and Drug Screening Model: A Strong Ally Against Covid-19 Jorge Galindo-Villegas
 [1] 

584 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.024 sec